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INTRODUCTION 
 
Smart nanostructured materials refer to the materials that can 
respond to external stimuli or to their environment, and owing to their small 
size and very large interfacial area; they possess specific properties and 
functions. These materials are useful for biomedical applications, for 
instance, site-specific drug delivery and tissue engineering. The 
mechanisms used to achieve novel drug delivery systems typically 
incorporate one or more of the following materials: biologics, polymers 
and/or silica based materials.  
The aim of this PhD work was to modify existing nanostructured 
materials by altering specific parameters. Three different types of non-ionic 
surfactants were utilized in this work to obtain diverse nanostructured drug 
delivery systems. Triblock copolymers of polyoxyethylene and 
polyoxypropylene viz. Pluronic F127 and Pluronic P123 were used to 
prepare thermoreversible gels and templates for the synthesis of 
mesoporous silica materials, respectively. A sorbitan alkyl ester - span 80 
was used in the preparation of gelatin microspheres. The monoglyceride 
surfactant monoolein was used to formulate different liquid crystalline 
structures and W/O emulsions stabilized by liquid crystalline phases. 
The model protein lysozyme and the small hydrophilic drug caffeine 
were used to evaluate loading and release performances. Three different 
types of formulations, mainly obtained using non-ionic surfactants, were 
characterized by techniques such as polarized light microscopy (PLM), 
scanning- and transmission electron microscopy (SEM and TEM), infrared 
(IR) spectroscopy, potentiometry, rheology, small angle X-ray scattering 
(SAXS), nuclear magnetic resonance (NMR) spectroscopy and N2 
adsorption/desorption. Structural features were then correlated with the in 
vitro release properties to study the effect of different variables. 
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1. GENERAL BACKGROUND 
 
1.1. Colloidal Systems 
The term colloid applies broadly to systems containing at least two 
components, in any state of matter, one dispersed in the other, where the 
dispersed component consists of large molecules or small particles [1]. 
Thus, they consist of a dispersed phase (or discontinuous phase) 
distributed uniformly in a finely divided state in a dispersing medium (or 
continuous phase). Colloids are broadly classified into three major classes 
viz. simple colloids, network colloids and multiple colloids. In case of simple 
colloids, for example emulsions and colloidal suspensions, a clear 
distinction between the dispersed phase and dispersing medium can be 
made. Another important example is association colloids, where molecules 
of surface active agents come together to form small aggregates (micelles) 
in water. The nanostructures formed by surfactant molecules can adopt an 
ordered structure to form liquid crystals. In case of network colloids, such 
as certain gels, it is hardly possible to distinguish the two phases as they 
consist of interpenetrating networks, the elements of each being of colloidal 
dimension. Multiple colloids involve co-existence of three phases of which 
two (and sometimes three) phases are finely divided. For example, multiple 
emulsions where water in oil emulsion is dispersed in water or oil in water 
emulsion is dispersed in oil [2]. 
The colloidal dispersed phase normally, but not necessarily, in all 
cases lie between 10-10000 nm [3]. It is not obligatory for all three 
dimensions to lie in these limits, since colloidal behavior is observed in 
some systems containing fibers in which only one dimension is in colloidal 
range. An alternative classification of colloids is based upon the type of 
dispersing medium i.e. lyophobic (or hydrophobic when dispersing medium 
is water) and lyophilic i.e. lyophilic (or hydrophilic when dispersing medium 
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is water) colloids, depending on whether particles can be described in the 
former case as ‘solvent hating’ or in the latter case as ‘solvent loving’ [2]. 
 
1.2. Surfactants and self-assembly 
Surfactants are low to moderate molecular weight compounds which 
contain one hydrophobic part, which is generally readily soluble in oil but 
sparingly soluble or insoluble in water, and one hydrophilic (or polar) part, 
which is sparingly soluble or insoluble in oil but readily soluble in water 
(Fig.1.1) [4]. 
 
Fig.1.1. Schematic illustration of a surfactant molecule. 
 
Due to this ‘‘schizophrenic’’ nature of surfactant molecules, they 
experience suboptimal conditions when dissolved molecularly in aqueous 
solution. If the hydrophobic segment is very large the surfactant will not be 
water-soluble, whereas for smaller hydrophobic moieties, the surfactant is 
soluble, but the contact between the hydrophobic block and the aqueous 
medium is energetically less favorable than the water-water contacts. 
Alternatives to a molecular solution, where the contact between the 
hydrophobic group and the aqueous surrounding is reduced, therefore offer 
ways for these systems to reduce their free energy. Consequently, 
surfactants are surface active, and tend to accumulate at various polar-
apolar interfaces, where the water contact is reduced [4].  
Polar
head group
Hydrophobic 
tail
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Another way to reduce the oil-water contact is self-assembly, through 
which the hydrophobic domains of the surfactant molecules can associate 
to form various structures, which allow a reduced oil-water contact. Various 
structures can be formed, including micelles, microemulsions, and a range 
of liquid crystalline phases (Fig.1.2). The type of structures formed depends 
on a range of parameters, such as the size of the hydrophobic tail, the 
nature and size of the polar head group, temperature, salt concentration, 
pH, etc. Through varying these parameters, one structure may also turn 
into another, which offers interesting opportunities in triggered drug delivery 
[4].  
The primary mechanism for surfactants to reduce the energy in most 
cases will be adsorption at the available interfaces. However, when all 
interfaces begin to be saturated, the overall energy reduction may continue 
through other mechanisms as illustrated in Fig.1.2 [3].  
 
Fig.1.2. Modes of surfactant action for reduction of surface and interfacial energies. 
 
Micelle 
formation
Liquid crystal 
formation
Adsorption at L/L 
interface
Adsorption at S/L 
interfaceor
Bilayer and vesicle 
formation
Crystalization
Adsorption at L/V interface
Monomer
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Micelles and liquid crystals formation is a process of thermodynamic 
random self-assembly whereas the formation of emulsions often involves a 
tricky, kinetically driven process. 
In the following sections these self-assembly structures are 
discussed individually in order of the complexity of the structures. 
 
1.2.1. Micelles and reverse micelles 
1.2.1.1. Micelles  
A micelle is a colloidal-size object that is formed by spontaneous 
association of surfactant molecules. When dissolved in aqueous medium 
part of the initially added surfactant molecules are adsorbed onto the air–
liquid interface and form an adsorbed monolayer. Since the space for the 
monolayer formation is limited at the surface, the rest of the molecules 
remain in the solution as a free form of molecules (monomers). In general, 
the main attractive driving force for the micellization (micelle formation) is 
the hydrophobic interaction (Fig.1.3).  
 
Fig.1.3. Micelle formation: micellization. 
 
As the concentration of surfactant increases, the monomers come 
close together because of this interaction. This also brings closely together 
the head groups, which can be either ionic (for ionic surfactants) or 
hydrated (for nonionic surfactants). Thus, the repulsive force between the 
head groups begins to arise on the surface of the self-assembled aggregate 
cmc
hydrophilic head
hydrophobic tail
monomer 2-20 nm
micelle
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(micelle). The transition of monomers into this self-assembled aggregate 
form occurs when these two opposite forces are balanced. The micelle is at 
equilibrium with monomers. For most of the surfactants, the initially formed 
micelle has spherical or near-spherical shape (close to ellipsoidal in the 
case of longer chain length). The monomer concentration where the first 
micelle begins to appear is defined as critical micelle concentration or cmc. 
Since pre-micellar aggregates are formed in many cases, this point for the 
cmc is not always clear cut. Thus, the cmc is often determined by the 
empirical average of the narrow ranges of concentration. Typical cmc 
ranges are from 10−5 to 10−2 mole/liter for most of the single-chain 
surfactants and the amphiphilic polymers, such as the Pluronic series. The 
aggregation number is the number of surfactant or polymer molecules 
within a micelle. It ranges 50-10,000. No micelle has a clear-cut 
aggregation number. It always shows a Gaussian-type distribution. Thus, 
the aggregation numbers from the references are the average number. 
Naturally, this is quite dependent on the measurement method and 
calculation process. So is the cmc. Studies using various techniques show 
that the state of the micelle core region is close to that of the bulk 
hydrocarbon. The microviscosity of the micelle core of typical surfactants 
ranges ∼10 - ∼50 cP at room temperature.  
Ninham et al. has proposed the concept of the surfactant (or micelle) 
packing parameter [5-7].  
 𝑃𝑃 = 𝑣𝑣
𝑎𝑎0 𝑙𝑙  (1) 
where v is the volume of the hydrocarbon chain of the surfactant 
monomer in the micelle, ao is the area occupied by the head group on the 
micelle surface, and l is the apparent length of the hydrocarbon chain of the 
surfactant monomer in the micelle. All these are the simple molecular 
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parameters of surfactant. The term aol has the dimension of volume; thus, P 
becomes a dimensionless parameter.  
 
Fig.1.4. Surfactant packing parameter (P). 
 
Once the three sub-parameters v, ao and l are estimated, it is 
possible to predict the most favored nanostructure using the surfactant 
packing parameter (Fig.1.4). For example, when the P-value is close to 1/3, 
one can predict the formation of a spherical micelle by the simple 
geometrical consideration of packing of cone-type monomer into three - 
dimensional self-assembled aggregate. Similarly, when the P-value is close 
to 1/2, one can predict that rod-like micelles will be formed. When the P-
value is close to 1, the unit packing shape becomes the cylinder type; thus 
a bilayer-type nanostructure is the most likely structure to be assembled. P 
> 1 results in reverse nanostructures (micelle). 
 
1.2.1.2. Reverse micelles 
The ideal reverse micelle should be composed of the surfactant 
molecules that are positioned in reverse compared with those of normal 
ao
ao
l
v
l (length)
v (volume)
(area)
micelle cross-section
P = 1/3
Spherical micelle
P = 1/2
Rodlike micelle
P = 1
Bilayer
P > 1
Reverse micelle
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micelles (Fig.1.12). To have thermodynamically stable reverse micelles that 
can be counterparts of normal micelles, there should be at least a minimum 
number of hydrated water molecules that can balance the repulsive force 
with the attractive hydrophobic force. When the content of water molecules 
increases, the core region of reverse micelles can hold additional water 
molecules that are not needed for the hydration of the polar head groups. 
This water droplet thus can be named as confined or nanoscale medium. 
 
1.2.2. Bilayers 
Typical surfactants are classified as cationic, anionic or zwitterionic , 
based on the intrinsic charge of their head groups (Fig.1.5). 
 
 
Fig.1.5. Typical surfactants which form bilayers. 
 
Those possessing P ≈ 1 usually have the capability to form bilayers. 
But they often require specific conditions that can ensure the increased 
hydrophobic interaction between surfactant hydrocarbon chains and/or the 
O
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decreased repulsive interaction between head groups. Thus, typical binary-
phase diagrams of such surfactants with water at these conditions show a 
wide range of micelle region (spherical, rodlike, wormlike, etc.) that is 
followed by a liquid crystal region at higher concentration [8]. 
 
Fig.1.6. Schematic representation of different types of bilayers. 
 
Bilayers serve as a basic repeating or building unit for a variety of 
macroscopic self-assembled structures. Fig.1.6 shows some examples of 
different types of bilayers. Lamellar liquid crystals are a stacked form of 
extended bilayer self-assembled units with one-dimension symmetry. The 
other two axes of the lamellar structures are dimensionless. Bicontinuous 
cubic liquid crystals consist of a regularly curved bilayer unit with clearly 
defined three-dimension geometry. Three typical geometries of 
bicontinuous cubic phases are Ia3d, Pm3n, and Im3m. There is one 
bicontinuous cubic melted phase referred as L3 or sponge phase, which 
consist of three-dimensional random multiply connected bilayer dividing the 
lamellar liquid crystal bicontinuous cubic
vesicle biological membrane
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solvent into two sub-volumes [9]. Some gels (hydrogel and organogel) are 
also stabilized by the action of the bilayer unit. A vesicle is a metastable 
suspension of spherical (globular) enclosed bilayers. A basic structure of 
biological membranes is a bilayer of various lipids with embedded proteins. 
 
1.2.3. Vesicles, liposomes, and niosomes 
When the packing geometry becomes slightly less than 1 for the 
outer layer and slightly more than 1 for the inner layer, vesicles are formed. 
Liposome refers to vesicles that are composed solely of lipids (both natural 
and synthetic).  
 
Fig.1.7. Schematic representation of different types of vesicles. 
 
Niosomes are vesicles formed by solely nonionic surfactants. The 
size of vesicles can range ~ 20 nm – ~ 50 μm in diameter, but the thickness 
of each single layer is limited to 3 – 5 nm [10].  
Fig.1.7 shows schematic representations of typical types of vesicles. 
They are usually classified in three groups based on their size and 
geometry: small unilamellar vesicle (those with radius below ~100 nm), 
Small 
unilamellar 
vesicle
large unilamellar 
vesicle
mulitilamellar vesicle
vesosome
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large unilamellar vesicle (those with radius above ~ 100 nm), and 
multilamellar vesicle [11]. A large unilamellar vesicle with different sizes of 
smaller unilamellar vesicles inside is named a vesosome. 
Vesicles, in most cases, are thermodynamically unstable but 
kinetically stable self-assembled aggregates. A vesicle “solution” is a 
dispersion of those aggregates. Thus, a variety of physicochemical 
properties of vesicles depend on preparation and post-preparation 
techniques such as sonication, filtration, extrusion, and so forth. These 
treatments in turn provide useful means to control size and shape of 
vesicles for given applications. 
  
1.2.4. Liquid crystals 
Liquid crystals show both crystalline solid and isotropic liquid 
characteristics at ambient temperature and pressure. They display some 
degree of geometrical ordering but with some degree of molecular mobility. 
Liquid crystals are thermodynamically stable and their phases are referred 
as mesophases. No strong bonds as those are involved in the solid state 
are responsible for the liquid crystalline state. Weak intermolecular forces 
are the only interactions responsible of this state. Their macroscopic 
appearance often looks like a gellish solid but with some degree of fluidity, 
and some of them show crystalline solid-like properties such as optical 
anisotropy. Based on the origin of intermolecular interactions that induce 
the ordering, liquid crystals are classified as thermotropic and lyotropic 
liquid crystals. Thermotropic liquid crystals are induced by temperature 
changes, while lyotropic liquid crystals are formed by the change of 
concentrations in the presence of a solvent.  
Surfactant liquid crystals have more variety of structural diversity 
than thermotropic liquid crystals and usually exist in equilibrium with 
monomers. They are often in equilibrium with other self-assembled 
12 
 
aggregates, including normal micelles, reverse micelles, vesicles, and 
microemulsions. 
 
Fig.1.8. (a) Structure of lamellar phase showing bilayers and (b) typical lamellar gel phase 
structures. 
 
Lamellar phases are the most common lyotropic mesophases and 
consist of surfactant bilayers separated by solvent layers (Fig.1.8.a). The 
lamellar phase has a bilayer structure, which has directional order and 
localized layer disorder. The surfactant head groups are located at the 
polar-apolar interface. The solvent layer thickness of a typical lamellar liquid 
crystal can vary from around 8 Å to greater than 100 Å depending on the 
composition, while the surfactant bilayer thickness is generally about 10-
50% less than twice the all-trans chain length. 
 
Fig.1.9. Reverse hexagonal (HII) and nomal hexagonal (HI) phases. 
 
Normal Bilayer Tilted Bilayer
Interdigitated Bilayer
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In many systems, at temperatures below that at which the lamellar 
phase forms, a gel phase (Lβ) exists. Such phases consist of similar bilayer 
structures to those in lamellar phases: however, the alkyl chains are frozen 
in an all-trans configuration (Fig.1.8.b) [12]. 
Lyotropic hexagonal mesophases consist of infinite liquid cylinders 
organized on a hexagonal lattice with surfactant polar heads located at the 
interface of the cylinders. For packing parameter P < 1, (hydrophilic 
surfactants), oil in water self-assembly structured (normal hexagonal or HI) 
phases are formed. Lipophilic surfactants (P > 1) form reverse self-
assembly structures (water in oil) commonly referred as the reverse 
hexagonal structure (HII) (Fig.1.9).  
 
Fig.1.10. Various types of cubic phases 
 
In case of lyotropic cubic phases, micelles arrange themselves in a 
cubic pattern. There are two distinct micellar aggregation shapes: the first 
one is spherical and forms the cubic discrete micellar (I) phase while the 
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second one is rod-like, interconnected in a three dimensional scheme and 
form the bicontinuous cubic (V) phase. The three common structures of 
bicontinuous cubic phases include double diamond (Pn3m), gyroid (Ia3d) 
and primitive (Im3m), whereas the common example of discrete cubic 
micellar phase is face centered cubic (fcc) or Fd3m (Fig.1.10).  From an 
optical point of view, all types of cubic phases present no texture, since 
they are isotropic and can be distinguished from the isotropic micellar 
solutions only by their high viscosity. The cubic phases I and V can be 
correctly identified one from another by their precise location among other 
phases. In the hypothesis of increasing progressively the surfactant 
concentration, the I phase location is between the isotropic micellar solution 
and the hexagonal one, while the V phase location is between the 
hexagonal phase and the lamellar one. However, only small angle X-ray 
scattering (SAXS) technique can assign the type of cubic liquid crystalline 
structure univocally.  
 
1.2.5. Emulsions 
A surfactant can be used to stabilize the mixture of two immiscible 
liquids (such as oil and water). The surfactants are self-assembled into 
protective layers at the interface between the two liquids, and dramatically 
decrease the interfacial tension between the two liquids, which stabilizes 
the water or oil droplets. The head group of the surfactant is toward water 
side, while the tail group is toward the oil phase. These systems are 
referred as emulsions. Two types of emulsion are possible, based on the 
ratio of water to oil phase. When the water is the disperse phase while oil 
forms the droplets, it is defined as oil-in-water emulsion (O/W). Water-in-oil 
(W/O) is the reverse situation, with water droplets in the oil-disperse phase. 
Emulsions are also classified as microemulsions and macroemulsions, 
depending on the size of the droplets and the thermodynamic properties. 
15 
 
In order to understand mechanism of formation and breakdown of 
macroemulsion, consider a system in which an oil is represented by a large 
drop 2 of area A1 immersed in a liquid 2, which is now subdivided into a 
large number of smaller droplets with total area A2 (such that A2 >> A1), as 
shown in Fig.1.11. The interfacial tension γ12 is same for the large and 
smaller droplets as the latter are generally in the region of 0.1 µm to few 
microns in size. 
 
Fig.1.11. Schematic representation of emulsion formation and breakdown. 
 
The change in free energy in going from state I to state II is given by 
two contributions: a surface energy term (that is positive) that is equal to 
ΔAγ12 (where ΔA=A2–A1); an entropy of dispersions term which is also 
positive (since the production of a large number of droplets is accompanied 
by an increase in configurational entropy) which is equal to TΔSconf.  
From the second law of thermodynamics, 
 ∆𝐺𝐺𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 = ∆𝐴𝐴𝛾𝛾12 − 𝑇𝑇∆𝑆𝑆conf  (2) 
In most cases, ΔAγ12 >>TΔSconf, which means that ΔGform can be 
positive – that is, the formation of emulsions is nonspontaneous, unless a 
strong decrease of γ12 occurs. When spontaneous emulsification takes 
place, a microemulsion, that is, thermodynamically stable system forms. 
2
1
I
Formation
Breakdown
2
II
1
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When the surfactant is not efficient enough in decreasing γ12, work must be 
added to obtain emulsification. In the last case, macroemulsions, that are 
kinetically stable systems only, are formed. Fig.1.12 illustrates the two 
situations just described. Typically, to obtain a microemulsion, γ12 must 
decrease at least 3-4 orders of magnitude with respect to the usual O/W 
values which range between 20-40 mN/m. 
 For many micro- and macroemulsions, a fourth important 
component named co-surfactant is needed to achieve satisfactory stability. 
 
Fig.1.12. Schematic representation of the relation of micelles, microemulsions, and 
macroemulsions. 
 
1.2.5.1. Microemulsions 
Microemulsion is a thermodynamically stable, transparent, low-
viscous and isotropic emulsion. Fig.1.12 shows the schematic 
representation of the formation of emulsions. When a small amount of oil is 
introduced into normal micellar solution, most likely a swollen micelle is first 
normal micelle micelle with 
solubilized lipophile
O/W microemulsion O/W macroemulsion
revrse micelle revrse micelle
with hydrated water
W/O microemulsion
W/O macroemulsion
thermodynamically stable, transparent, low-vosous kinetically stable, turbid, high-vosous
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formed as the oil (or hydrophobic molecule) is solubilized inside the normal 
micelle. This is a typical micellar solubilization. As more oil is solubilized, 
the micelle swells further, and oil droplets begin to be formed inside the 
micelle. This oil droplet stays in almost a pure oil phase, but not as the 
mixture of oil and hydrocarbon chain of surfactant. This ideal state thus can 
be regarded as the oil droplets emulsified (or stabilized) by surfactant layers 
in the water phase. This is the O/W microemulsion. In case of these 
thermodynamically stable systems also bicontinuous nanostructures, as in 
the case of cubic liquid crystals, have been reported. 
 
1.2.5.2. Macroemulsions 
Macroemulsion may be defined as an opaque, heterogeneous 
system of two immiscible liquid phases (oil and water) where one of the 
phases is dispersed in the other as drops of microscopic or colloidal size 
(typically around 1 µm). There are two kinds of simple macroemulsions viz. 
oil-in-water (O/W) and water-in-oil (W/O), depending on which phase 
comprise the drops. Macroemulsions made by the agitation of the pure 
immiscible liquids are very unstable and break rapidly to the bulk phases. 
They may be stabilized by the addition of surfactants, which protect the 
newly formed droplets from coalescence [13].  
In the absence of any stabilization mechanism, the emulsion will 
break by flocculation, coalescence, Ostwald ripening, or a combination of 
all these processes.  
This situation is illustrated graphically in Fig.1.13 where several 
paths for emulsion breakdown processes are represented. In the presence 
of a stabilizer (surfactant), an energy barrier is created between the 
droplets and therefore the reversal from state II to state I become non- 
continuous as a result of the presence of these energy barriers (Fig.1.11). 
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Thus, in the presence of the energy barriers, the system becomes 
kinetically stable. 
 
Fig.1.13. Schematic representation of the various breakdown processes in emulsions. 
 
The physical phenomena involved in each breakdown process are 
not simple, and requires an analysis of the various surface forces involved. 
In addition, these processes may take place simultaneously rather than 
consecutively, which in turn complicates the analysis. Model 
macroemulsions, with monodisperse droplets, cannot be easily produced 
and hence any theoretical treatment must take into account the effect of 
polydispersity. In addition, the measurement of surfactant adsorption in 
macroemulsion is not simple, and such information must be extracted from 
measurements made at a planar interface [14]. 
 
A summary of each of the breakdown processes is provided in the 
following sections, together with details of each process. 
Sedimentation
Coalescence
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1.2.5.3.1. Creaming and Sedimentation 
Creaming is the process by which buoyant macroemulsion droplets 
tend to rise to the top of a container. It is the same process as 
sedimentation, but in the opposite direction [15]. This process results from 
external forces, usually gravitational or centrifugal. When such forces 
exceed the thermal motion of the droplets (Brownian motion), a 
concentration gradient builds up in the system such that the larger droplets 
move more rapidly either to the top (if their density is less than that of the 
medium) or to the bottom (if their density is greater than that of the medium) 
of the container. In the limiting cases, the droplets may form a close-packed 
(random or ordered) array at the top or bottom of the system, with the 
remainder of the volume occupied by the continuous liquid phase. 
 
1.2.5.3.2. Flocculation  
This process refers to aggregation of the droplets (without any 
change in primary droplet size) into larger units. It is the result of the van 
der Waals attractions which are universal with all disperse systems. 
Flocculation occurs when there is not sufficient repulsion to keep the 
droplets apart at distances where the van der Waals attraction is weak. 
Flocculation may be either strong or weak, depending on the magnitude of 
the attractive energy involved.  
 
1.2.5.3.3. Ostwald Ripening 
Ostwald ripening in macroemulsions is the growth of one droplet at 
the expense of a smaller one due to the difference in chemical potential of 
the continuous phase between different droplets arising from their different 
radii of curvature. This chemical potential increases with decreasing radius 
and consequently the solubility of the material comprising the droplet phase 
increases. The smaller droplets thus tend to dissolve and their material 
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diffuses through the bulk phase and re-deposits onto a larger droplet, 
resulting in an overall increase in the average radius of the macroemulsion. 
Ostwald ripening generally proceeds with the cube of the average radius 
varying linearly with time. As the radius of the emulsion droplets increases, 
the rate of change in droplet radius falls rapidly since dr/dt = (1/r2)dr3/dt; 
thus, for a given rate of ripening, the rate of change in radius falls as r-2 [16]. 
 
1.2.5.3.4. Coalescence  
This refers to the process of thinning and disruption of the liquid film 
between the droplets, with the result that fusion of two or more droplets 
occurs to form larger droplets. The limiting case for coalescence is the 
complete separation of the emulsion into two distinct liquid phases. The 
driving force for coalescence is the surface or film fluctuations; this results 
in a close approach of the droplets whereby the van der Waals forces are 
strong and prevent their separation. 
 
1.2.5.3.5. Phase Inversion  
Phase inversion refers to the phenomenon when an O/W 
macroemulsion, quite suddenly changes its morphology and becomes a 
W/O macroemulsion [17]. In many cases, phase inversion passes through a 
transition state whereby multiple emulsions are produced. 
 
1.3. Drug delivery systems 
 Successful drug delivery requires consideration of numerous 
aspects. Depending on the route of administration, the disease or disorder, 
the properties of the drug, and many other aspects, various strategies have 
to be developed. Without doubt the most generically important aspects of 
any therapy are its efficacy and safety [4]. First and foremost, the drug 
concentration should be sufficiently high at the site of action in order to 
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have a therapeutic effect, but at the same time it should not be too high, 
since this may result in detrimental side effects. For a safe and efficient 
therapy, the drug concentration should preferably lie essentially constant 
within ‘‘therapeutic window’’ over the time of action (Fig.1.14). 
 
Fig.1.14. Schematic illustration of the drug level for an ideal sustained release formulation 
(solid line) and of a more typical situation demanding repeated administration (dotted line).  
  
The goal of a constant drug concentration within the therapeutic 
window at the site of action over a suitable therapeutic time puts 
requirements not only on the drug but also on the drug formulation. The 
drug delivery system should preferably be designed so that a preferential 
accumulation of the drug is reached at the site of action, whereas the drug 
concentration elsewhere in the body should be as low as possible. The 
reason for this need of ‘‘targeting’’ is that a high concentration of the drug in 
tissues or cells other than those being targeted may cause problems 
related to side effects. A typical example of the latter is cancer therapy, 
where accumulation of chemotherapeutic agents in areas other than the 
tumor frequently causes severe side effects, some of which may be dose 
limiting, thereby limiting also the efficacy of the treatment [18]. Furthermore, 
the drug should be stable against degradation during storage and 
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administration, and the formulation designed so that drug degradation is 
minimized. Once the drug has performed its action, however, it should 
either be straightforwardly excreted or metabolized to harmless 
compounds. There are also many other aspects to a drug delivery system, 
e.g., in relation to the route of administration. Naturally, the preferred 
situation is that the drug is straightforwardly administrable by the patient 
himself/herself, without unpleasant sensations. However, depending on a 
number of different aspects also other routes may be chosen. The complete 
therapeutic strategy therefore involves choice not only of the drug but also 
of the drug delivery system and the administration route. Different routes of 
administration put different requirements on the drug delivery system, and 
consequently different drug delivery systems tend to have their primary 
application within a given route of administration, and within a certain type 
of indication. For example, in oral drug delivery, the drug and the drug 
carrier have to pass through the stomach, with its quite low pH, which tends 
to affect drug stability and drug solubility, as well as the properties of the 
drug carrier system. Also, the uptake in the intestine puts some rather 
demanding requirements on the drug and the drug formulation, not the least 
for hydrophobic drugs and/or large molecules (e.g., protein and peptide 
drugs). In topical administration the penetration over the stratum corneum 
poses a severe limitation in the therapy efficacy, which puts special 
demands on the drug delivery system. In intravenous drug delivery, the 
uptake of the drug and the drug carrier in the reticuloendothelial system 
frequently reduces the drug bioavailability and results in dose-limiting side 
effects.  
 
For this thesis work, three different drug delivery systems mainly 
based upon non-ionic surfactants were studied and are briefly described in 
following sections. 
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1.3.1. Microspheres suspended in thermosensitive gels 
Microspheres are usually solid, approximately spherical particles 
containing dispersed drug in either solution or microcrystalline form. 
Incorporation of drugs can be achieved by entrapment during production 
(polymerization, gelation, or encapsulation techniques, such as 
coacervation and phase separation) and by covalent and ionic attachment. 
Microspheres may be prepared from natural polymers such as gelatin and 
albumin [19-20] and from synthetic polymers such as polylactic and 
polyglycolic acid [21-22]. The drug is either totally encapsulated within a 
distinct capsule wall or is dispersed throughout the microsphere. Drug 
release is controlled by dissolution and diffusion of the drug through the 
microsphere matrix or the microcapsule wall, or by polymer degradation. 
Microspheres range in size between approximately 1 and 1000 µm. 
Consequently, these systems are outside the conventional colloidal size 
range. In the pharmaceutical literature, however, microcapsules with sizes 
up to approximately 15 µm are considered as colloidal-delivery systems 
[23]. 
Chemical or physical crosslinking of some polymers leads to 
hydrogel formation which absorbs a considerable amount of water while 
maintaining their shape. Injectable hydrogels are of great interest as 
potential materials for protein delivery [24]. Especially, thermo-sensitive and 
sol–gel transition water soluble polymers can provide in-situ forming 
hydrogels for delivery of therapeutic molecules upon injection into the body 
without an invasive surgical procedure [25]. Physically crosslinked 
hydrogels self-assembled as a result of intermolecular ionic interactions, 
hydrogen bonding, and hydrophobic interactions are advantageous for 
macromolecular delivery systems, since they provide a more benign 
environment for encapsulation of proteins, compared to chemically 
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crosslinked hydrogels. Various synthetic thermo-sensitive polymers such as 
poly(N-isopropylacrylamide) [26], polyphosphazenes[27], poly(ethylene 
oxide) (PEO)/poly(propylene oxide) (PPO) tri-block copolymers [28], and 
PEO/poly(d,l-lactide-co-glycolide) (PLGA) tri-block copolymers [29] have 
been extensively studied for use as injectable sol–gel transition hydrogel 
systems for pharmaceutical and biomedical applications. Among these, a 
series of PEO–PPO–PEO tri-block copolymers (or Pluronics) has been 
widely exploited as in-situ forming drug delivery carriers because they 
exhibit unique sol–gel transition behaviors in response to temperature 
variations in aqueous solution. These tri-block copolymers form spherical 
micelles in aqueous solution by hydrophobic interaction between the middle 
PPO segments [30]. Above a critical gelation temperature and 
concentration, the self-assembled micelles are closely packed to produce a 
physically crosslinked gel structure. This consists of discrete cubic micellar 
phase, as described in section 1.2.4. However, the Pluronic hydrogels are 
very soft and easily disintegrated and dissolved out upon contact with 
excess amount of buffer solution. This is due to the fact that the 
concentration of Pluronic copolymers is immediately diluted to below the 
critical gelation concentration, resulting in the dis-assembling of the micellar 
structure. Thus, when a highly concentrated aqueous solution of Pluronic 
copolymer is injected into the body tissue as a sol state, the in-situ formed 
gel structure cannot be maintained for the desired period to achieve 
sustained release of encapsulated drugs.  
A combination of microspheres and hydrogel has been attempted by 
many researchers for various reasons. The examples include 5-Fluorouracil 
in chitosan microspheres and Pluronic F127 (PF127)  gel [31], insulin in 
calcium-alginate microspheres and PF127 gel [32], Baclofen in poly(lactide-
co-glycolide) (PLGA) microspheres dispersed in chitosan and PF127 gels 
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[33], timolol maleate in Poly(adipic anhydride)  microspheres and gelrite gel 
[34], oxybenzone in gelatin microspheres and aloe vera gel [35].  
1.3.2. Ordered mesoporous materials 
The porosity of a ceramic matrix can be ordered or disordered. It is 
clear that a well-ordered pore distribution in a ceramic matrix favors the 
homogeneity of the adsorption and release stages [36]. Ordered silica 
mesoporous materials are potentially excellent candidates in the field of 
controlled drug delivery systems for pharmaceutical drugs, proteins and 
other biogenic molecules. Since the discovery of ordered mesoporous silica 
materials in 1990s, synthesis and applications of mesoporous solids have 
received intensive attention due to their highly ordered structures, larger 
pore size, and high surface area [37].  
 
Table 1 Porous structures of mesoporous materials. 
Mesoporous 
solid Space group 
Pore diameter 
 (nm) Structure 
MCM-41 P6mm 2-5 Hexagonal 1D channel 
MCM-48 Ia3d 2-5 Bicontinuous 3D 
SBA-15 P6mm 5-10 Hexagonal 1D channel 
SBA-16 Im3m Min 1-6; max 4-9 Body centre arrangement of cages 
SBA-1 Pm3m 2-4 Cubic 3D 
SBA-3 P6mm 2-4 2D hexagonal 
MSU P6mm 2-5 2D hexagonal 
HMS P6mm  2-5 Hexagonal 
 
Table 1 presents the porous structure of some mesoporous 
materials, which have been employed for drug delivery [37]. Vallet-Regi et 
al. in 2000 has reported the application of MCM-41 as a new drug delivery 
system [38]. This has stimulated many researchers to develop different 
types of mesoporous materials with varying porous structure and 
functionality for sustained drug released and stimuli-responsive release. 
MCM-41 shows hexagonal arrays of cylindrical mesopores. The structure of 
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the wall of the pores consists of a disordered network of siloxane bridges 
and free silanol groups that could act as reacting nuclei against appropriate 
guest chemical species, behaving as a matrix for controlled adsorption and 
liberation of organic molecules. The pore morphology and clearance 
determine the type of molecules that can fit into these materials and, 
therefore, those that are eligible for the adsorption process; however, the 
maximum amount accepted depends on the pore volume, which is 
generally described in terms of cm3g-1 of material. In systems that only 
contain mesopores, the total pore volume is evidently equal to the 
mesopore total volume, but this is not generally the case. Frequently, there 
are also micropores or even macropores (pores with diameter larger than 
50 nm); this last type of pore is usually associated to interparticle porosity, 
and its contribution to the total pore volume increases with decreasing 
particle size in the material. Undoubtedly, the specific surface is a 
parameter that influences the adsorption properties of the material, since it 
is a surface phenomenon itself. The concept of surface encompasses not 
only the outer surface of the material, but also the inner surface of its 
cavities and channels, provided that the nitrogen-based molecules used in 
these measurements can pass freely through these inner areas [39].  
 
1.3.3. Liquid crystals and emulsions 
The description about various liquid crystals has been given in 
section 1.2.4. The stabilization of emulsions by lamellar liquid crystals has 
been reported by Friberg et al. [40]. In order to further stabilize emulsions, 
crystallization of lamellar liquid crystalline phases located at the water/oil 
interface resulting in the formation of a so-called gel phase has been 
reported [41-43]. It has been demonstrated by Engels et al. that changes in 
the type and concentration of the co-emulsifier caused the formation of a 
lamellar gel phase surrounding the oil droplets inside an oil-in-water (O/W) 
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emulsion which increased the stability of the emulsion from 5 days to more 
than 1 month [43]. It was found that the physico-chemical properties of the 
system remained unaffected by the change of the co-surfactant. It was 
proved that the presence of the lamellar liquid crystalline phase causes the 
observed increase in emulsion stability. The viscous lamellar film 
surrounding the emulsion droplets may be several layers thick and reduces 
the attraction potential between the droplets. As a result, the lamellar layer 
acts as a barrier against coalescence [44]. 
Emulsions containing a third phase or multimolecular layers of 
lyotropic liquid crystals are often found in cosmetic products and are 
therefore widely used by the cosmetics industry to adjust or optimize 
specific properties of the product such as viscosity or consistency, storage 
stability or application convenience [45]. 
Recently, it has been reported that the long-term stable 
W/O emulsions can be obtained by dispersing water in the lamellar and 
reverse hexagonal phases formed by monoolein-based systems [46-47]. 
Skin permeation experiments demonstrated that emulsions containing liquid 
crystalline phases compared to an emulsion without liquid crystals, showed 
enhanced skin penetration of the hydroquinone and octadecenedioic acid. 
The increase in skin penetration was attributed to an increased partitioning 
of the drugs into the skin. In the case of salicylic acid, no effect of liquid 
crystalline phases in emulsion on penetration was observed. This effect 
was suggested to be due to different interaction of drug and surfactants 
forming liquid crystalline phases in emulsions [48]. 
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2. THEORETICAL BACKGROUND 
 
2.1. Microscopy 
2.1.1. Polarized light microscopy 
Polarized light microscopy (PLM) is one of the important techniques 
for identification of lyotropic liquid crystals (except cubic mesophases) 
because anisotropic liquid crystals show birefringence similar to crystalline 
solids. Each liquid crystal shows typical black and white textures. In the 
case of an additional λ-plate with strong birefringent properties, color effects 
of the textures can also be observed [1]. Hexagonal mesophases can be 
recognized by their typical fan shape texture (Fig.2.1.a) [2]. Lamellar 
mesophases typically show oily streaks with inserted maltese crosses 
(Fig.2.1.b). The latter result from defect structures, called confocal domains 
that arise from concentric rearrangement of plane layers [3]. In some 
lamellar mesophases these defects prevail. Hence no oily streaks occur but 
mosaic pattern can be observed (Fig. 2.1.c). A drawback of PLM is that it is 
restricted to particle dimensions in the micron or submicron range whereas 
colloidal dimensions of liquid crystals are only resolved by transmission 
electron microscopy (TEM). 
   
Fig.2.1. Characteristic pattern of liquid crystalline phases (a) hexagonal fan-like structure, 
(b) lamellar maltese crosses and (c) lamellar mosaic pattern.  
 
2.1.2. Electron Microscopy 
There are two types of electron microscopes – the scanning electron 
microscope (SEM) and the transmission electron microscope (TEM). These 
(a) (b) (c) 
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devices require measurements to be undertaken in a vacuum, except for 
the environmental SEM. Also, the samples must be conducting (in order to 
accelerate the electrons onto the sample) and, hence, a sample must have 
a metal layer deposited on its surface if it is to be investigated by SEM or 
TEM. In the TEM, the sample is a very thin specimen and contrast within 
the image is due to the spatial variations in intensity of the transmitted 
electron beam through the specimen, as the beam is raster scanned over 
the specimen. In the SEM, the image may be produced in a number of 
ways – from variations in the intensity of secondary electrons back-
scattered from the specimen through to X-ray emission produced by 
inelastic collisions of the primary beam with bound electrons in the 
specimen. The idea that gave rise to the electron microscope is that, just as 
light is refracted and focused by an optical lens, the electron, due to its 
charge, will have its path deviated by either a magnetic field or an electric 
field. Therefore, with careful design of appropriate electric and magnetic 
fields within the instrument, an electron beam may be focused like an 
optical beam [4].  
In case of TEM microscope, the electrons are emitted by an 
incandescent cathode source, and accelerated towards more positive grids 
through either electrostatic or magnetic field lens onto an object. The 
specimen is supported on a very thin film to minimize the scattering of the 
electrons as they pass through the sample. Depending on the thickness 
and composition of the object, the electron beam experiences different 
attenuation as a function of position. The beam travels through two more 
lenses before being imaged onto a fluorescent screen (in original models) 
or photographic plate or directly onto a scintillator placed on the face of a 
photomultiplier tube or a CCD device. (A scintillator is a semi-transparent 
material, which emits a flash of light when a charged particle traverses it.) 
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Fig.2.2. Comparison of a basic operation of (a) standard optical microscope, (b) an 
electrostatic version of electron microscope and (c) a magnetic coil version of electron 
microscopes. 
 
The spatial resolution of this type of microscope is determined by the 
wavelength associated with the electrons and this wavelength may be 
100,000 times smaller than optical wavelengths at the typical accelerating 
voltages used in electron microscopy [5]. 
TEM in a high-resolution (nanometer resolution) mode can be used 
with thin ultra-microtomed specimens 40–60 nm thick. Fine structural 
details, smaller than 1 nm are detectable by this microscope. In Fig.2.2 (b) 
and (c), the schematic diagram of a transmission electron microscope 
system is shown. The parallel illuminating electron beam is scattered by the 
object. The scattered beam passes through the convergent lens, L, and is 
focused in the intermediate image focal plane as an electron diffraction 
pattern. The final optical image is formed in the Gauss plane. For the 
magnified image to be a reliable Fourier synthesis, all of the beams must 
interfere whilst keeping their initial relative phases. The objective lens will 
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introduce additional phase shifts. These phase shifts vary as a function of 
the spherical aberration Cs of the lens, the diffraction angle, 2θ, of the 
beams relative to the optic axis and the defocus distance, Δf . The transfer 
function of the electron beam lens, K, has been shown to  
 𝐾𝐾(𝑢𝑢) = 𝐷𝐷(𝜆𝜆𝑓𝑓𝑢𝑢)𝑒𝑒−𝑖𝑖𝑖𝑖 (𝑢𝑢) (1) 
where χ(u) = π(1/2Csλ3u4−λΔfu4) and D is the characteristic function 
of the objective aperture, χ(u) is the aberration function, u is the spatial 
frequency (u=2θ/λ), f is the focal image distance and λ is the wavelength. 
The objective acts like a filter for spatial frequencies, selecting and 
modifying the phase of planar waves that can interfere in the image plane 
[6]. 
Typical acceleration voltages are V=120 kV, which gives the electron 
an energy, E = 120 keV (where 1 electronVolt, eV is equivalent to an 
energy of 1.6 × 10-19 Joules) and the representative wavelength, λ, for 
these electrons is 3.35 × 10-3 nm, computed from the non-relativistic De 
Broglie expression 
 
𝜆𝜆 = ℎ
�2𝐸𝐸𝑓𝑓𝑒𝑒  (2) 
where me is the electronic mass. Hence, the electron microscope 
has potentially, one of the highest spatial resolutions of all of the 
microscope techniques.  
The electron microscope (like any other microscope) can be 
considered as an information channel that carries information from object to 
observer. The overall model for the electron microscope contains 
parameters, e.g. atomic coordinates which are unknown and which must be 
determined by experiment. Structure determination can be achieved by 
fitting the model to the experimental data in an iterative procedure in which 
the model parameters are systematically refined. By implication, details 
beyond the Rayleigh point resolution (and even beyond the information limit 
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of the microscope) may be extracted because, in the absence of noise (and 
assuming that the model is correct), the fitting procedure would be perfect 
and exact values of the model parameters would be obtained! In practice, 
however, results will always be limited by some noise component, e.g. the 
Poisson noise due to the counting statistics (quantum or shot noise) which 
is determined by the number of electrons in the illuminating beam. In 
scanning electron microscopes, low energy secondary electrons (Ee < 50 
eV) are detected using a scintillator/pm tube detector. At these low 
energies, the secondary electrons can only escape, and be detected, from 
within a few nanometers of the surface of the specimen [7].  
 
2.2. ATR-FTIR Spectroscopy  
Infrared spectroscopy is a technique based on the vibrations of the 
atoms of a molecule. An infrared spectrum is commonly obtained by 
passing infrared radiation through a sample and determining what fraction 
of the incident radiation is absorbed at a particular energy. The energy at 
which any peak in an absorption spectrum appears corresponds to the 
frequency of a vibration of a part of a sample molecule. 
Processes of change, including those of vibration and rotation 
associated with infrared spectroscopy, can be represented in terms of 
quantized discrete energy levels E0, E1, E2, etc., as shown in Fig.2.3.  
 
Fig.2.3. Illustration of quantized discrete energy levels. 
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Each atom or molecule in a system must exist in one or other of 
these levels. In a large assembly of molecules, there will be a distribution of 
all atoms or molecules among these various energy levels. The latter are a 
function of an integer (the quantum number) and a parameter associated 
with the particular atomic or molecular process associated with that state. 
Whenever a molecule interacts with radiation, a quantum of energy (or 
photon) is either emitted or absorbed. In each case, the energy of the 
quantum of radiation must exactly fit the energy gap E1 − E0 or E2 − E1, etc. 
The energy of the quantum is related to the frequency by the following: 
 Δ𝐸𝐸 = ℎ𝜈𝜈 (3) 
Hence, the frequency of emission or absorption of radiation for a 
transition between the energy states E0 and E1 is given by: 
 𝜈𝜈 = (𝐸𝐸1 − 𝐸𝐸0)/ℎ (4) 
Associated with the uptake of energy of quantized absorption is 
some deactivation mechanism whereby the atom or molecule returns to its 
original state. Associated with the loss of energy by emission of a quantum 
of energy or photon is some prior excitation mechanism. Both of these 
associated mechanisms are represented by the dotted lines in Fig.2.3. 
The interactions of infrared radiation with matter may be understood 
in terms of changes in molecular dipoles associated with vibrations and 
rotations. The frequency of vibrational modes depends upon the stiffness of 
the bond and the masses of the atoms at each end of the bond. The 
stiffness of the bond can be characterized by a proportionality constant 
termed the force constant, k (derived from Hooke’s law). The reduced 
mass, μ, provides a useful way of simplifying calculations by combining the 
individual atomic masses, and may be expressed as follows: 
 �1 𝜇𝜇� � = �1 𝑓𝑓1� � + �1 𝑓𝑓2� � (5) 
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where m1 and m2 are the masses of the atoms at the ends of the 
bond. A practical alternative way of expressing the reduced mass is: 
 𝜇𝜇 = 𝑓𝑓1𝑓𝑓2/(𝑓𝑓1 + 𝑓𝑓2) (6) 
The equation relating the force constant, the reduced mass and the 
frequency of absorption is: 
 𝑣𝑣 = (1/2𝜋𝜋)√(𝑘𝑘 ⁄ 𝜇𝜇) (7) 
This equation may be modified so that direct use of the wavenumber 
values for bond vibrational frequencies can be made, namely: 
 ?̅?𝑣 = (1/2𝜋𝜋𝜋𝜋)√(𝑘𝑘 ⁄ 𝜇𝜇) (8) 
where c is the speed of light.  
A molecule can only absorb radiation when the incoming infrared 
radiation is of the same frequency as one of the fundamental modes of 
vibration of the molecule. This means that the vibrational motion of a small 
part of the molecule is increased while the rest of the molecule is left 
unaffected. 
Vibrations can involve either a change in bond length (stretching) or 
bond angle (bending). Some bonds can stretch in-phase (symmetrical 
stretching) or out-of-phase (asymmetric stretching). If a molecule has 
different terminal atoms such as HCN, ClCN or ONCl, then the two 
stretching modes are no longer symmetric and asymmetric vibrations of 
similar bonds, but will have varying proportions of the stretching motion of 
each group. In other words, the amount of coupling will vary. 
Bending vibrations also contribute to infrared spectra and these are 
summarized in Fig.2.4.  
 
Fig.2.4. Different types of bending vibrations. 
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It is best to consider the molecule being cut by a plane through the 
hydrogen atoms and the carbon atom. The hydrogens can move in the 
same direction or in opposite directions in this plane, here the plane of the 
page. For more complex molecules, the analysis becomes simpler since 
hydrogen atoms may be considered in isolation because they are usually 
attached to more massive, and therefore, more rigid parts of the molecule 
[8]. This results in in-plane and out-of-plane bending vibrations, as 
illustrated in Fig.2.5. 
 
Fig.2.5. Out-of-plane and in-plane bending vibrations. 
 
Fourier-transform infrared (FTIR) spectroscopy is based on the idea 
of the interference of radiation between two beams to yield an 
interferogram. The latter is a signal produced as a function of the change of 
pathlength between the two beams. The two domains of distance and 
frequency are interconvertible by the mathematical method of Fourier-
transformation [9]. 
The essential equations for a Fourier-transformation relating the 
intensity falling on the detector, I(δ), to the spectral power density at a 
particular wavenumber, ν, given by B(.ν), are as follows: 
 
𝐼𝐼(𝛿𝛿) = � 𝐵𝐵(?̅?𝜈+∞
−∞
) cos(2𝜋𝜋?̅?𝜈𝛿𝛿)𝑑𝑑?̅?𝜈 (9) 
which is one half of a cosine Fourier-transform pair, with the other 
being: 
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𝐵𝐵(?̅?𝜈) = � 𝐼𝐼(𝛿𝛿+∞
−∞
) cos(2𝜋𝜋?̅?𝜈𝛿𝛿)𝑑𝑑𝛿𝛿 (10) 
These two equations are interconvertible and are known as a 
Fourier-transform pair. The first shows the variation in power density as a 
function of the difference in pathlength, which is an interference pattern. 
The second shows the variation in intensity as a function of wavenumber. 
Each can be converted into the other by the mathematical method of 
Fourier-transformation. 
Attenuated total reflectance (ATR) spectroscopy utilizes the 
phenomenon of total internal reflection (Fig.2.6).  
 
Fig.2.6. Schematic of a typical attenuated total reflectance cell. 
 
A beam of radiation entering a crystal will undergo total internal 
reflection when the angle of incidence at the interface between the sample 
and crystal is greater than the critical angle, where the latter is a function of 
the refractive indices of the two surfaces. The beam penetrates a fraction of 
a wavelength beyond the reflecting surface and when a material that 
selectively absorbs radiation is in close contact with the reflecting surface, 
the beam loses energy at the wavelength where the material absorbs. The 
resultant attenuated radiation is measured and plotted as a function of 
wavelength by the spectrometer and gives rise to the absorption spectral 
40 
 
characteristics of the sample [10]. The depth of penetration in ATR 
spectroscopy is a function of the wavelength, λ, the refractive index of the 
crystal, n2, and the angle of incident radiation, θ. The depth of penetration, 
dp, for a non-absorbing medium is given by the following: 
 𝑑𝑑𝑝𝑝 = (𝜆𝜆/𝑛𝑛1)/{2𝜋𝜋[𝑠𝑠𝑖𝑖𝑛𝑛𝑠𝑠 − (𝑛𝑛1/𝑛𝑛2)2]}  (11) 
where n1 is the refractive index of the sample. 
The crystals used in ATR cells are made from materials that have 
low solubility in water and are of a very high refractive index. Such 
materials include zinc selenide (ZnSe), germanium (Ge) and thallium–
iodide (KRS-5). Different designs of ATR cells allow both liquid and solid 
samples to be examined [10].  
 
2.3. Small Angle X-ray Scattering (SAXS) 
Small angle X-ray scattering (SAXS) is a small angle scattering 
technique where the elastic scattering of X-rays by a sample which has 
structure in the nanometer-range, is recorded at very low angles (0.1 - 10°). 
This angular range contains information about the shape and size 
of macromolecules, pore sizes, unit cell distances of liquid crystalline 
phases etc.  
In a SAXS instrument a monochromatic beam of X-rays is brought to 
a sample from which some of the X-rays scatter, while most go through the 
sample without interacting with it. The scattered X-rays form a scattering 
pattern which is then detected at a detector which is typically a 2-
dimensional flat X-ray detector situated behind the sample perpendicular to 
the direction of the primary beam that initially hit the sample. The scattering 
pattern contains the information on the structure of the sample. 
Elastic interactions are characterized by zero energy transfers, such 
that the final wave vector kf is equal in modulus to ki. The relevant 
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parameter to analyze the interaction is the momentum transfer or scattering 
vector q=ki-kf, given by equation:  
 q = 4πsin(θ) / λ (12) 
 
Fig.2.7. Schematic representation of the scattering vector 
 
where 2θ is the angle between the incident X-ray beam and the 
detector measuring the scattered intensity, and λ is the wavelength of the 
X-rays.  
With X-ray scattering experiments characteristic interferences are 
generated from an ordered microstructure [11]. A typical interference 
pattern arises due to specific repeat distances of the associated interlayer 
spacings d. According to Bragg’s equation d can be calculated: 
 𝑑𝑑 = 𝑛𝑛𝜆𝜆/2𝑠𝑠𝑖𝑖𝑛𝑛𝛾𝛾 (13) 
where n is an integer and nominates the order of the interference, 
and γ is the angle under which the interference occurs (reflection conditions 
are fulfilled). 
From Bragg’s equation it can be seen that the interlayer spacing d is 
inversely proportional to the angle of reflection γ. Large terms for d in the 
region of long-range order can be measured by small-angle X-ray 
diffraction (SAXD), while small terms for d in the region of short-range order 
can be investigated by wide-angle X-ray diffraction (WAXD). SAXD is the 
most appropriate technique for the exact determination of the distances of 
interlayer spacings of liquid crystalline systems. The short-range order of 
crystalline nano-suspensions can be detected by WAXD. Interferences can 
be detected by using either film detection, or scintillation counters or 
Kf
Ki
q
2θ
q = Kf - Ki
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position-sensitive detectors. However, in addition to interference detection, 
and subsequent calculation of interlayer spacings of the crystalline material, 
the SAXS method enables the sequence of the interferences and thus the 
type of ordering to be detected [12]. 
Small-angle scattering (SAXS) is a powerful technique for examining 
nanostructures formed by the self-assembly of surfactants and block 
copolymers. SAXS is extensively used to identify morphologies in the self-
assembled structures from the sequence of Bragg reflections observed. 
Table 1 lists the positions of peaks for the equilibrium structures observed 
in various liquid crystal structures. Multiple orders of Bragg reflection are 
observed for strongly segregated samples. Weakly segregated samples 
may only exhibit the lower order peaks, which can lead to ambiguities in 
phase identification. This can be circumvented by supplementary 
information from a complementary technique, for example, transmission 
electron microscopy. Alternatively, shear alignment of a sample can 
enhance the information content in a SAXS pattern, and facilitate the 
identification of morphology even for a weakly segregated sample. SAXS 
methods are well suited to investigate the structure of micelles because 
their size is typically ~5–100 nm, which leads to scattering at small 
angles[13]. 
 
Table 1 Peak positions (expressed as q/q*) of Bragg reflections for various structures. 
 
Structure Ratio (q/q*) 
Lam 1, 2, 4, 5, 6,....... 
Hex (p6mm) 1,√3, √4, √7, √9, √12,......... 
BCC (Im3m) 1, √2, √3, √4, √5, √6,........ 
FCC (Fm3m) 1, √4/3, √8/3, √11/3, √12/3, √16/3,........ 
Gyr (Ia3d) 1, √4/3, √7/3, √8/3, √10/3, √11/3,......... 
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2.4. Rheology of gels 
A gel system is composed of molecules that form a network and 
these molecules are linked either by chemical crosslinks, similar in strength 
to the molecular bonds, or physical links, which are considerably weaker. 
This definition covers a wide range of systems from proteins, lipids, and 
surfactants to polymers [14-15]. 
Experimentally, rheology is the study of the effects of shear on a 
system. The response of a system can comprise of two basic components. 
The system can either acts as a spring, returning the energy imparted to it, 
or it can act as a damper and dissipate the applied energy as heat. These 
two behaviours are termed elastic and viscous behavior, respectively. Gels 
show both these effects and are thus viscoelastic materials [16]. 
Let us consider a cube of material of height, h, with a fixed base. 
When a force, F, is applied to the top of the material’s surface, it causes a 
deformation, du 
 
Fig.2.8. The effect of a shear force, the horizontal scale is exaggerated. 
 
The shear strain deformation, or strain as it is simplified, is written 
as: 
 𝛾𝛾 = 𝑑𝑑𝑢𝑢 ℎ⁄  (14) 
There are no units for strain, and it is often expressed as a 
percentage. The applied force per unit area is the shearing stress, or shear 
du
h
Force
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stress, measured in Pascals. The shear modulus, G, can be defined as the 
ratio of the shearing force to the shearing strain amplitude: 
 𝐺𝐺 = 𝜎𝜎/𝛾𝛾 (15) 
In general G is a complex quantity. If the cube is a viscous liquid, 
when we apply a force we now get a constant flow rather than just a 
deformation. This can be described as a strain changing as a function of 
time. The rate of change of strain is known as the shear rate, and generally 
has units of reciprocal seconds. 
The viscosity is defined as: 
 𝜂𝜂 = 𝑆𝑆ℎ𝑒𝑒𝑎𝑎𝑓𝑓 𝑓𝑓𝑎𝑎𝑟𝑟𝑒𝑒 𝑆𝑆ℎ𝑒𝑒𝑎𝑎𝑓𝑓 𝑠𝑠𝑟𝑟𝑓𝑓𝑒𝑒𝑠𝑠𝑠𝑠⁄  (16) 
The combination of hydrophobic blocks and hydrophilic blocks 
causes the systems to associate intermolecularly to form transient 
networks. A transient network allows for the hydrophobic end groups to 
detach from the micelles. Once detached, a chain is free to move 
independent of the rest of the network. Motion of the chains is governed by 
Rouse dynamics with a characteristic time, τR. 
So, relaxation time = detachment time +Rouse time. 
 𝜏𝜏 = 𝛽𝛽0−1 + 𝜏𝜏𝑅𝑅 (17) 
The relaxation time when the stress and elongation have reached 
equilibrium is equal to η/G, where G is the modulus. 
 𝛾𝛾𝑟𝑟𝑓𝑓𝑟𝑟𝑎𝑎𝑙𝑙 = 𝑆𝑆𝑒𝑒𝑙𝑙𝑎𝑎𝑠𝑠𝑟𝑟𝑖𝑖𝜋𝜋 + 𝛾𝛾𝑣𝑣𝑖𝑖𝑠𝑠𝜋𝜋𝑓𝑓𝑢𝑢𝑠𝑠  (18) 
This can be expressed as 
 𝑑𝑑𝛾𝛾 𝑑𝑑𝑟𝑟⁄ = 𝑆𝑆 𝜂𝜂⁄ + 𝑑𝑑𝑆𝑆 𝑑𝑑𝑟𝑟 ∙ 1 𝐺𝐺⁄  ⁄  (19) 
i.e. Rate of strain is equal to zero under conditions of constant 
stress. So, 
 𝑆𝑆/𝜂𝜂 + 𝑑𝑑𝑆𝑆/𝑑𝑑𝑟𝑟. 1/𝐺𝐺 = 0 (20) 
Assuming S=S0 at time zero 
 𝑆𝑆 = 𝑆𝑆0 ∙ 𝑒𝑒−𝑟𝑟 𝜏𝜏⁄  (21) 
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So, according to the Maxwell model, under conditions of constant 
strain, the stress will decrease exponentially with time and at the relaxation 
time will be equal to 1/e, of its original value. 
In the Maxwell model the viscoelastic moduli are given by: 
 𝐺𝐺′(𝜔𝜔) = (𝐺𝐺∞𝜔𝜔2𝜏𝜏2)(1 + 𝜔𝜔2𝜏𝜏2)(Storage modulus) (22) 
 𝐺𝐺′′ (𝜔𝜔) = (𝐺𝐺∞𝜔𝜔𝜏𝜏)(1 + 𝜔𝜔2𝜏𝜏2)(Loss modulus) (23) 
ω – Angular frequency (rad s-1) 
τ – Stress relaxation time. 
 tan 𝛿𝛿 = 𝐺𝐺′′ /𝐺𝐺′ (24) 
This ratio is loss tangent, and is a measure of the energy loss per 
cycle. 
In general G is both a complex quantity, comprising of storage (real) 
(G') and loss (imaginary) (G'') components and frequency dependent, 
showing vastly different behavior at low shear rates and high shear rate 
[17]. 
As concentration is increased, the ‘‘symmetric’’ diblocks such as 
PEO-PPO-PEO copolymers, which have  a roughly equal number of 
hydrophobic and hydrophilic groups show a progression in the following 
order [18]: 
 
Isotropic micellar         cubic micellar         hexagonal         lamellar structure 
 
This is analogous to the phase behavior seen in surfactant solutions. 
The phase behavior of PEO-containing copolymers corresponds to 
fascinating rheological properties; the most notable is formation of a cubic 
gel from low viscosity solutions as the temperature is increased. 
Rheological ‘phase boundaries’ can be measured for several copolymers 
which show transitions between sols, ‘soft gels,’ and ‘hard gels’. The sol–
hard gel transition corresponds to the formation of a close-packed 
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micellar gel, described above. The soft gels, on the other hand, show a 
fractal structure consistent with the idea of a percolated network of micelles 
[19]. The soft gel transition has also been ascribed to a spherical-to-
cylindrical micelle transition [20-21] or the occurrence of defects in 
the cubic phase [22-23]. 
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3. MICROSPHERES SUSPENDED IN PLURONIC F127 GEL 
 
3.1. Introduction 
Among the different types of drug delivery systems being proposed 
recently, microspheres composed of biodegradable polymers for controlled 
release applications are extensively studied [1]. Gelatin is one of the 
common natural polymers used in the fabrication of particulate drug 
delivery systems such as microspheres [2-4]. It is a well known natural 
polymer derived from collagen which possesses good biodegradability and 
biocompatibility [2, 5-6]. Moreover, it has been extensively used in various 
contemporary pharmaceutical dosage forms, and it is included on the FDA 
list of inactive ingredients [7]. Gelatin exhibits polyion complexation 
properties which can be utilized in the formulation of the sustained release 
of numerous charged pharmacologically active molecules including proteins 
[5-6]. Different cross-linking methods have been reported for gelatin 
microspheres (GMs) in order to alter the toxicity associated with cross-
linking agents [8].  
In this context, it should be remarked that GMs, due to their 
biodegradability, are not expected to fulfill all requirements of an effective 
controlled release, in terms of pharmacokinetic protocols. Burst release 
cannot be avoided unless a protection that slows down the degradation 
process is adopted. To obtain sustained release drug delivery systems, 
combinations of microspheres and gel systems have been attempted 
previously by several authors. Examples include 5-Fluorouracil in chitosan 
microspheres and PF127 gel [9], insulin in calcium-alginate microspheres 
and PF127 gel [10], Baclofen in Poly(lactide-co-glycolide) (PLGA) 
microspheres dispersed in chitosan and PF127 gels [11], timolol maleate in 
Poly(adipic anhydride) microspheres and gelrite gel [12], oxybenzone in 
gelatin microspheres and aloe vera gel [13].  
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The present work focuses on GMs dispersed in the thermosensitive 
Pluronic F127 (PF127) gel matrix. The concentrated aqueous solutions (20-
40 % w/v) of Pluronic F127 (PF127), a synthetic triblock copolymer, show 
thermoreversible properties due to interactions between different segments 
of the copolymer along with hydration strength. Above the Krafft 
temperature, that was found to be approximately 12 ºC [14-15], PF127 
molecules (concentration around, 20 % w/v) form O/W micelles. The 
micelle structure consists of almost spherical arrangement of copolymer 
with a dehydrated polypropylene oxide core and an outer shell of hydrated 
swollen polyethylene oxide chains. With increasing temperature ordered 
packing of micelles leads to gelation of aqueous solution of PF127 [16]. 
PF127 gels can be useful to enhance the stability and the protection of 
proteins. They do not show any inherent myotoxicity with single or multiple 
injections [17]. This polymer has been reported in literature for delivery of 
various protein/peptide drugs such as insulin [18], urease [19], interleukin-2 
[20], epidermal growth factor [21], bone morphogenic protein (BMP) [22],  
and basic fibroblast growth factor (bFGF) [23]. Most release profiles show 
sustained release kinetics over several hours.  
The aim of the present work was to investigate the effect on 
morphology and release performance of two different crosslinking methods 
in the preparation of GMs loaded with lysozyme chosen as a model protein. 
To the best of our knowledge, the combination of GMs and PF127 gel has 
never been reported. Lysozyme is a small antibacterial protein with 
molecular weight of 14.4 kD useful for the treatment of prosthetic valve 
endocarditis [24-25]. Another important aim of this work was to investigate 
the release performance modifications produced by suspending the 
lysozyme loaded GMs in PF127 gel, and to ascertain that lysozyme does 
not lose its activity due to the preparation conditions of the formulation or 
during the release. Scanning Electron Microscopy (SEM), ATR-Fourier 
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Transform Infrared (FTIR) Spectroscopy and Small-Angle X-Ray Scattering 
(SAXS) techniques along with rheological measurements were used to 
characterize morphology and physico-chemical properties of the 
formulations. The quantification of lysozyme loading and release was 
performed through lysozyme activity assay using Micrococcus lysodeikticus 
bacterial suspension [26].  
 
3.2. Materials and methods 
3.2.1. Materials 
Hen egg white lysozyme (isoelctric point ~11), gelatin B (isoelectric 
point 4.7-5.2), D-glucose, Span 80, acetone, Pluronic F127, potassium 
dihydrogen orthophosphate and dipotassium hydrogen phosphate were 
purchased from Sigma aldrich. Millipore filtered and distilled water was 
used wherever required.  
 
3.2.2. Preparation of gelatin microspheres 
Glucose cross-linked gelatin microspheres (GluGM) and 
glutaraldehyde cross-linked gelatin microspheres (GAGM) were prepared 
with and without lysozyme loading. Both types of GMs were prepared by 
thermal gelation method as first described by Tabata and Ikada and later 
modified by several authors [2, 27-28]. For GluGM, 400 mg of D-glucose 
was dispersed in 20 ml of an aqueous gelatin B solution (20 %, w/v, 
preheated at 40 ⁰C) and the dispersion was added drop wise to mixture of 
soya oil and Span 80 (1 % v/v) while stirring the mixture at 1000 rpm at 80 
⁰C for 10 min. This gave water in oil (W/O) emulsion. Stirring was continued 
for further 10 min while decreasing the temperature to 15 ⁰C. Then 150 ml 
of acetone was added to dehydrate and flocculate the microspheres. After 
10 min of stirring microspheres were then filtered through sintered glass 
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filter and washed with 250 ml of acetone to remove residual oil. GluGMs 
were dried under vacuum to remove acetone. For preparing, lysozyme 
loaded GluGM (LGluGM), 100 mg of lysozyme was dissolved in gelatin and 
glucose-D solution. In case of GAGM, first gelatin microspheres without 
cross-linking were obtained through the same procedure as that of GluGM 
without the addition of sugar. These GMs were then mixed with 0.22 M 
glutaraldehyde prepared in aqueous ethanol solution (90 % v/v) with stirring 
for 45 min and then with 99.8 % ethanol for 4 hours to remove excess of 
glutaraldehyde. GAGMs were vacuum dried to evaporate residual ethanol. 
For preparing lysozyme loaded GAGMs (LGAGM), GAGMs were 
suspended in 10 mg/ml of lysozyme prepared in phosphate buffer pH 7.4 
for 24 hours. The resulting LGAGMs were separated from the lysozyme 
solution and freeze dried. All the microspheres were stored in closely 
packed glass vial. 
 
3.2.3. Lysozyme activity 
Lysozyme activity was measured by a method reported in literature 
[26]. Micrococcus lysodeikticus (Sigma) bacterial cell suspension was used 
to quantitatively determine the bioactivity of the enzyme. Lysozyme is 
known to digest the cell wall of bacteria. The bacterial cells were dispersed 
in potassium phosphate buffer (66 mM, pH 6.24) in the concentration of 
0.015% w/v. It was further diluted with the same buffer so that initial 
absorbance was approximately 1.50 at 450 nm. An appropriately diluted 
lysozyme solution (0.1 ml) was added into 2.5 ml of bacterial suspension 
and the absorbance at 450 nm was recorded every 15 s during a total 
incubation period of 5 min at 25 °C. The bioactive lysozyme concentration 
was determined by the following equation 
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 𝑈𝑈𝑛𝑛𝑖𝑖𝑟𝑟𝑠𝑠/ 𝑓𝑓𝑙𝑙 𝑙𝑙𝑙𝑙𝑠𝑠𝑓𝑓𝑙𝑙𝑙𝑙𝑓𝑓𝑒𝑒=  (∆𝐸𝐸450𝑛𝑛𝑓𝑓 / min𝑇𝑇𝑒𝑒𝑠𝑠𝑟𝑟 −  ∆𝐸𝐸450𝑛𝑛𝑓𝑓 / min𝐵𝐵𝑙𝑙𝑎𝑎𝑛𝑛𝑘𝑘)(𝑑𝑑𝑓𝑓)(0.001)(0.1)  (1) 
 
where ∆E450nm/min is the reduction in the absorbance at 450 nm per 
minute, df is the dilution factor, 0.001 is the change in absorbance at 450 
nm as per the unit definition of lysozyme activity, 0.1 is volume (in ml) of 
lysozyme used for the assay. 
 
3.2.4. Drug loading and encapsulation ratio of microspheres 
Both types of lysozyme loaded gelatin microspheres (5 mg) were 
dispersed in 10 ml distilled water with the help of magnetic stirrer. The 
concentration of bioactive lysozyme was monitored till it becomes constant 
by the method described in section 3.2.3. The drug loading (LD) and 
encapsulation ratio (ED) were determined by using following equations: 
 𝐿𝐿𝐷𝐷= 
𝐴𝐴𝜋𝜋𝑟𝑟𝑢𝑢𝑎𝑎𝑙𝑙 𝑙𝑙𝑓𝑓𝑎𝑎𝑑𝑑𝑒𝑒𝑑𝑑 𝑎𝑎𝑓𝑓𝑓𝑓𝑢𝑢𝑛𝑛𝑟𝑟 𝑓𝑓𝑓𝑓 𝑙𝑙𝑙𝑙𝑠𝑠𝑓𝑓𝑙𝑙𝑙𝑙𝑓𝑓𝑒𝑒  𝑓𝑓𝑜𝑜𝑟𝑟𝑎𝑎𝑖𝑖𝑛𝑛𝑒𝑒𝑑𝑑 𝑜𝑜𝑙𝑙 𝑒𝑒𝑒𝑒𝑟𝑟𝑓𝑓𝑎𝑎𝜋𝜋𝑟𝑟𝑖𝑖𝑓𝑓𝑛𝑛 × 100
𝐴𝐴𝑓𝑓𝑓𝑓𝑢𝑢𝑛𝑛𝑟𝑟 𝑓𝑓𝑓𝑓 𝑓𝑓𝑖𝑖𝜋𝜋𝑓𝑓𝑓𝑓𝑠𝑠𝑝𝑝ℎ𝑒𝑒𝑓𝑓𝑒𝑒𝑠𝑠  (2) 
 𝐸𝐸𝐷𝐷= 
𝐴𝐴𝜋𝜋𝑟𝑟𝑢𝑢𝑎𝑎𝑙𝑙 𝑙𝑙𝑓𝑓𝑎𝑎𝑑𝑑𝑒𝑒𝑑𝑑 𝑎𝑎𝑓𝑓𝑓𝑓𝑢𝑢𝑛𝑛𝑟𝑟 𝑓𝑓𝑓𝑓 𝑙𝑙𝑙𝑙𝑠𝑠𝑓𝑓𝑙𝑙𝑙𝑙𝑓𝑓𝑒𝑒  𝑓𝑓𝑜𝑜𝑟𝑟𝑎𝑎𝑖𝑖𝑛𝑛𝑒𝑒𝑑𝑑 𝑜𝑜𝑙𝑙 𝑒𝑒𝑒𝑒𝑟𝑟𝑓𝑓𝑎𝑎𝜋𝜋𝑟𝑟𝑖𝑖𝑓𝑓𝑛𝑛 × 100
𝐴𝐴𝑓𝑓𝑓𝑓𝑢𝑢𝑛𝑛𝑟𝑟 𝑓𝑓𝑓𝑓 𝑙𝑙𝑙𝑙𝑠𝑠𝑓𝑓𝑙𝑙𝑙𝑙𝑓𝑓𝑒𝑒 𝑎𝑎𝑑𝑑𝑑𝑑𝑒𝑒𝑑𝑑 𝑟𝑟𝑓𝑓 𝑟𝑟ℎ𝑒𝑒 𝑝𝑝𝑓𝑓𝑒𝑒𝑝𝑝𝑎𝑎𝑓𝑓𝑎𝑎𝑟𝑟𝑖𝑖𝑓𝑓𝑛𝑛  (3) 
 
3.2.5. Preparation of gel and microsphere/gel suspension 
PF127 gel was prepared by dissolving 20 % w/v of PF127 powder in 
distilled water for 12 to 24 hours at 4 ⁰C in refrigerator. This method of 
preparation is called as ‘cold method’ [29]. The lysozyme was dissolved in 
distilled water for preparing lysozyme loaded PF127 gel. Lysozyme loaded 
gelatin microspheres were added to PF127 gel to form gelatin microsphere 
in PF127 gel formulation just before the experiment.  
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3.2.6. Microscopy 
The prepared gelatin microspheres were observed under scanning 
electron microscope to study shape and surface properties. The gelatin 
microspheres were sprinkled onto a double adhesive tape fixed on 
aluminium stage. Fixed microspheres were spattered with platinum film. 
Examination of microspheres was performed with a scanning electron 
microscope FE Hitachi S4000 operating at 15–20 KV.  
 
3.2.7. ATR-FTIR studies 
ATR-FTIR studies were conducted with a Bruker Tensor 27 
spectrophotometer equipped diamond ATR accessory and DTGS 
(deuteriotriglycine sulphate) detector. Each spectrum was an average of 
128 scans at resolution of 4 cm-1 from wavenumber 4000 to 400 cm-1. The 
Opus spectroscopic software was used for data handling.  
 
3.2.8. Rheology 
Rheological measurements were performed with rheometer (Malvern 
Kinexus, Worcestershire, UK) using cone-plate geometry CP4/40 and a 200 
µm gap operating in the oscillation mode. The frequency and shear stress 
was set as 0.1 Hz and 0.5 Pa. The temperature ramp was performed from 
5-40 ⁰C at 1 ⁰C/min rate. The sampling interval was set 5 seconds. The 
oscillatory measurements gave the information about the rheological 
parameters such as elastic or storage modulus (G') and the loss or viscous 
modulus (G''). Sol-gel transition temperature was determined for all the gel 
samples.  
 
3.2.9. SAXS experiments 
Small-angle X-ray diffraction was recorded with a S3-MICRO 
SWAXS camera system (HECUS X-ray Systems, Graz, Austria). Cu Kα 
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radiation of wavelength 1.542 Å was provided by a GeniX X-ray generator, 
operating at 50 kV and 1 mA. A 1D-PSD-50 M system (HECUS X-ray 
Systems, Graz, Austria) containing 1024 channels of width 54.0 μm was 
used for detection of scattered X-rays in the small-angle region. The 
working q-range (Å−1) was 0.003 ≤  q ≤ 0.6, where q = 4π sin (θ) λ−1 is the 
modulus of the scattering wave vector. The distance between the sample 
and detector was 235 mm. Solutions were usually taken from storage under 
refrigerator, heated to the required temperature and allowed 15 min to 
equilibrate. A few milligrams of the sample were enclosed in a stainless 
steel sample holder using a polymeric sheet (Bratfolie, Kalle) window. The 
diffraction patterns were recorded at 37 °C for 3 hours. To minimize 
scattering from air, the camera volume was kept under vacuum during the 
measurements. Silver behenate (CH3-(CH2)20-COOAg) with a d spacing 
value of 58.38 Å was used as a standard to calibrate the angular scale of 
the measured intensity. The lattice parameters (a) were determined for the 
cubic phases from the linear fits of the reciprocal spacing (1/dhkl) of the 
various reflections versus the sum of the Miller indexes (h2 + k2 +l2)1/2. For a 
correct assignment the plot passes through the origin, and the slope is 1/a, 
where ‘a’ is the lattice parameter.  
 
3.2.10. In vitro release studies 
For gelatin microspheres alone, 5 mg weighed amount lysozyme 
loaded GM was put in test tube along with 5 ml of release media. Aliquot of 
2 ml sample of the supernatant solution after a brief centrifugation was 
withdrawn at predetermined time-points and replaced with 2 ml fresh 
phosphate buffer. 
Membrane-less diffusion system was used for studying the release 
of lysozyme from LGAGM and LGluGM suspended in PF127 gel [30]. 
Accurately weighed 1 g sample of each type was put in a flat-bottomed vial 
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(internal diameter about 18 mm) followed by gently adding 1 ml of 
phosphate buffer (pH 7.4) on the surface of gels, and then the vial was 
shaken in a thermostatic shaker under 37 °C at 100 rpm. Complete 
supernatant solution was withdrawn at predetermined time-points and 
replaced with equal amount of fresh phosphate buffer. The concentration of 
bioactive lysozyme in the supernatant solution was determined using the 
method described in section 3.2.3. In order to estimate the lysozyme 
release from lysozyme loaded gelatin microspheres, unloaded 
microspheres were subjected to same release conditions to obtain the 
actual release. 
 
3.3. Results and discussion 
3.3.1. Preparation of gelatin microspheres 
Gelatin microspheres are normally prepared by the simple method of 
thermal gelation, also referred as emulsification-solvent-extraction method. 
In order to reduce the immediate quick dissolution of gelatin, and hence a 
burst release of the drug encapsulated within the microspheres, several 
cross-linking methods have been proposed. Chemical cross-linking of 
gelatin is frequently adopted by many researchers to decrease the solubility 
of GMs and consequently to decrease the rate of release of drugs from the 
microspheres. Di- or polyaldehydes used as cross-linking agents are known 
to give excellent microspheres for controlling release properties of 
encapsulated drug. However, these cross-linking agents lead to several 
undesirable toxic side effects, if traces of them remain after crosslinking 
and/ or if they form toxic products after reaction with the encapsulated drug. 
To overcome this problem several ‘natural’ cross-linking agents, for 
example sugars or sugar-derived compounds have been attempted for the 
preparation of microspheres with modified release profiles of the 
encapsulated drugs. The two representative compounds of chemical cross-
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linkers (i.e. Di- or polyaldehydes and sugars) for gelatin microspheres 
selected for this study are glutaraldehyde and D-glucose. There are several 
different mechanisms proposed for cross-linking of gelatin using 
glutaraldehyde or D-glucose. In case of crosslinking by glutaraldehyde, 
because of aldehyde functional groups, it is suggested that reaction occurs 
mainly with the ε-amino groups of gelatin lysyl residues, ultimately forming 
the GAGM i.e. glutaraldehyde crosslinked gelatin microsphere (Fig.3.1.a). 
In case of D-glucose, a possible mechanism of reaction is that the sugar 
aldehyde group reacts with the free ε-amino groups of gelatin molecule 
producing aminoglycoside, which further reacts with another amine group 
producing the GluGM i.e. glucose crosslinked gelatin microsphere 
(Fig.3.1.b).  
 
 
Fig.3.1. Cross-linking reaction of gelatin with (a) glutaraldehyde and (b) D-glucose. 
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Lysozyme has isoelectric pH of ~11, therefore, when it is adsorbed 
on the gelatin surface, it can react through the mechanism of poly-ion 
complexation.  Gelatin B (isoelectric pH 4.7-5.2) was preferred over gelatin 
A (isoelectric pH 7.0-9.0) due to its higher anionic nature.  
 
Table 1 Loading and entrapment ratio of lysozyme loaded gelatin microspheres. 
 LD (%) ED (%) 
LGAGM 7.0 ± 0.2 7.0 ± 0.2 
LGluGM 1.96 ± 0.04 98 ± 2 
 
The loading and encapsulation efficiencies of the two types of GMs 
viz. LGAGM and LGluGM, used in this study differed significantly from each 
other as reported in Table 1. These differences are mainly due to different 
methods used for loading the lysozyme into the microspheres. In case of 
LGAGMs, the loading of lysozyme was done after preparing the GAGMs. In 
case of LGluGMs, lysozyme was added before the emulsification in the 
aqueous gelatin and glucose solution. In a latter case, almost all the 
lysozyme was loaded successfully with entrapment efficiency (ED) equal to 
98 ± 2 %. For LGAGMs, the ED was lower since excess amount of 
lysozyme was used for loading procedure. Nevertheless, ED of LGAGMs 
(7.0 ± 0.2 %) was lower. Conversely, its loading capacity (LD) was 
significantly higher (7.0 ± 0.2 %) than that of LGluGMs (1.96 ± 0.04 %). It is 
noteworthy that in both the cases, the lysozyme did not lose its biological 
activity during the harsh conditions of formulation as determined through 
the methods described above (Section 3.2.3).  
 
3.3.2. Microscopy 
The lysozyme loaded GMs obtained through the two different cross-
linking procedures described in section 3.2.1, were dried under vacuum and 
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then further characterized by SEM technique. The images of both types of 
microspheres revealed that they were nearly spherical in shape (Fig.3.2.a 
and d) with some differences in external surface texture (Fig.3.2.b and e). 
The LGAGMs were smoother than the LGluGMs. LGluGMs showed a wavy 
surface with the presence of small plaques. Our observation about the 
surface morphology of glucose and glutaraldehyde crosslinked 
microspheres is consistent with the literature [2, 27]. These differences in 
surface properties could be the effect of different cross-linking agent. 
 
 
 
Fig.3.2. SEM micrographs of the lysozyme loaded glucose (LGluGM) (a, b and c) and 
glutaraldehyde (LGAGM) (d, e and f) crosslinked gelatin microspheres. 
  
   
Fig.3.3. Size distribution histograms for (a) lysozyme loaded glutaraldehyde (LGAGM) and 
(b) glucose (LGluGM) crosslinked gelatin microspheres. 
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The formulation parameters which can significantly affect the particle 
size, surface morphology, and dispersion of gelatin microspheres are the 
concentration of gelatin solution, the concentration of the emulsifier, the 
W/O ratio, the emulsifying time, and the stirring speed [31]. Therefore, 
concentration of gelatin solution as 20 % w/v, concentration of emulsifier 
(Span 80) as 1 % v/v, W/O ratio as 0.05, emulsifying time 10 min and 
stirring speed 1000 rpm were kept constant in order to study the effect of 
the two different crosslinking agents on the release properties.  
The image analysis of SEM micrographs leads to obtain size 
distribution and other interesting features induced by the different cross-
linkers. Fig.3.3.a and b shows size distribution histograms for LGAGM and 
LGluGM, respectively. It is clear from the size distribution histograms that 
the particle size distribution of LGAGM and LGluGM were different. Both 
types of gelatin microspheres showed log-normal size distribution.  
 
Table 2 Size distribution parameters for LGluGM and LGAGM. 
Parameter LGluGM (µm) LGAGM (µm) 
Mean 15.91 22.06 
Standard Deviation 6.63 13.68 
Minimum 4.80 2.72 
Median 14.50 17.39 
Maximum 48.02 70.49 
D90* 25.23 42.65 
* 90 % of particles are of size less than (µm) 
 
Table 2 summarizes the various size distribution parameters for the 
two types of GMs investigated. For LGAGM and LGluGM, mean particle 
size was approximately 22 µm and 16 µm, respectively. In case of LGAGM 
D90 (90% of microspheres are smaller than that) was about 43 µm whereas 
in case of LGluGM it was about 25 µm. This clearly shows that the 
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microspheres formed with glucose as crosslinking agent were relatively 
smaller in size than those with glutaraldehyde. The reason for this 
difference could also be attributed to the different methods adopted for the 
production of microspheres. For LGluGM, glucose was added before the 
emulsification step whereas in case of LGAGM, crosslinking by 
glutaraldehyde was done after the formation of uncrosslinked gelatin 
microspheres. The crosslinking procedure involves suspension of 
microspheres in the glutaraldehyde ethanol solution for 4 hours. During this 
time, it is likely that some of the microspheres swell by absorbing 
considerable amount of ethanol inside them. This results in the formation of 
cavities inside the microspheres, which can be identified in SEM 
micrograph. These microspheres did not collapse or shrink even after 
freeze drying. An example can be seen in Fig.3.2.f, where the cross-section 
of a large particle gives a clear evidence of a cavity. In addition it was 
noteworthy that when these microspheres were suspended in aqueous 
medium some of them floated on the surface due to the cavity inside them. 
The cross-section of LGluGM shows that there is no cavity inside the GM 
(Fig.3.2.c). 
 
3.3.3. ATR-FTIR studies 
ATR-FTIR technique was used to get qualitative information on the 
degree of crosslinking of gelatin microspheres prepared with the two 
different cross-linking agents. The infrared spectra of uncross-linked gelatin 
microspheres (GMs) and lysozyme loaded gelatin microspheres cross-
linked by glucose (LGlUGM) and glutaraldehyde (LGAGM) are shown in 
Fig.3.4. The IR spectra of all the GMs show the characteristic absorption 
peaks of protein due to NH and CO stretching.  The NH stretching also 
referred as Amide A peak is observed at about 3300 cm-1 and CO 
stretching peaks, also referred as Amide I, II and III, were found at about 
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1650, 1550 and 1240 cm-1, respectively. The intensity of the CO stretching 
peaks was very high when glutaraldehyde was used for cross-linking, 
followed by glucose, thus indicating that more carboxyl groups were 
activated for LGAGM than for LGluGM. An additional strong absorption 
peak, characteristic of an aldimine stretching vibration, is observed at about 
1450 cm-1. The formation of aldimine functional groups in case of glucose 
and glutaraldehyde crosslinking of gelatin has already been mentioned in 
the reaction mechanism. This confirms the occurrence of cross-linking 
reaction but with significant differences in the degree of cross-linking. 
Glutaraldehyde clearly favors the cross-linking reaction. 
 
Fig.3.4. ATR-FTIR spectra of (a) lysozyme loaded glutaraldehyde cross-linked (LGAGM); 
(b) lysozyme loaded glucose cross-linked (LGluGM) and (c) uncross-linked gelatin 
microspheres without lysozyme (GM). 
 
3.3.4. Rheological characterization 
In order to understand the sol-gel transition process and viscoelastic 
behavior of Pluronic F127 thermosensitive gels, rheological characterization 
was performed according to other works reported in literature [32-35]. 
Rheological data reported in Fig.3.5 show the sol-gel transition 
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temperatures of 20 % w/v PF127 alone and in the presence of LGAGM and 
LGluGM; these temperatures were found to be 21.90, 21.87 and 21.86 ºC 
respectively as shown in Table 3. The thermoreversible sol-gel transition of 
PF127 solutions occurs due to close micellar packing. It is worth noting that 
when the LGluGM or LGAGM are added to the PF127 solutions, the 
micelles become more closely packed and the volume fraction of PF127 
copolymer molecules decreases as reported in Table 4. Consequently a 
weakening of the elastic modulus of the gels may result. 
 
Fig.3.5. Change of elastic modulus as a function of temperature for (from top to bottom) (a) 
20 % w/v PF127, (b) 20 % w/v PF127–0.5 % w/v LGluGM and (c) 20 % w/v PF127–0.5 % 
w/v LGAGM.  
 
Table 3 Phase transition temperature and complex viscosity data for PF127 gel, PF127 gel 
with LGluGM and LGAGM. 
Sample Transition 
temperature (⁰C) 
Viscosity (PaS) with increasing 
temperature (⁰C) 
20 25 35 
PF 21.90 0.105 15544.86 21650.36 
PF+LGAGM 21.87 0.078 10393.58 14524.34 
PF+LGluGM 21.86 0.083 11023.00 16551.24 
 
Viscosity data at increasing temperature were obtained through the 
oscillatory measurements in order to ascertain the practical application of 
final formulations.  
Temperature ⁰C
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Table 3 summarizes relevant rheological and viscosity parameters. It 
can be noted that the viscosity at 20 ºC was very low in all cases. This 
implies that these formulations have the desired characteristic of being 
liquid at lower temperature. Viscosity increases sharply at room 
temperature and further at 30 ºC. At the investigated temperatures, i.e. 20, 
25 and 30 ºC, complex viscosity was significantly lower when either 
LGAGM or LGluGM were added to the PF127 solutions.  
 
3.3.5. SAXS 
Above the sol-gel transition temperature, the PF127-water systems 
show peculiar features that are not typical for gels. Indeed the close 
micellar packing produces a long-range ordered nanostructure that is a 
discrete cubic liquid crystal. The structural characterization  was done 
according to the methods reported in ref [36]. The PF127 nanostructure 
was determined by the relative positions of the Bragg peaks in the SAXS 
diffraction patterns.  
 
Fig.3.6. SAXS patterns of (a) PF127 20 % w/v gel (b) PF127 20 % w/v gel with 0.5 % w/v 
lysozyme loaded glucose crosslinked gelatin microspheres (c) PF127 20 % w/v gel with 
0.5 % w/v lysozyme loaded glutaraldehyde crosslinked gelatin microspheres. 
 
Fig.3.6 shows the SAXS patterns of (a) PF127 20 % w/v gel, (b) 
PF127 20 % w/v gel with 0.5 % w/v LGluGMs and (c) PF127 20 % w/v gel 
with 0.5 % w/v LGAGMs. The three patterns are strikingly similar and show 
at least five weak Bragg peaks with relative positions in ratios √3 : 2 : √8 : 
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√11 : √12... which can be indexed as hkl = 111, 200, 220, 311, 222 
reflections of a face centered cubic phase of Fm3m space group (Q225). 
Although the SAXS pattern is essentially dominated by a Fm3m structure, 
several weak non-indexable peaks are visible. 
Two parameters are characteristic of the nanostructure of the liquid 
crystalline phases: the lattice parameter a, and the interfacial area per PEO 
block, ap. In the normal micellar cubic structure the interfacial area per PEO 
block can be calculated from: 
 𝑎𝑎𝑝𝑝 = (36𝜋𝜋𝑛𝑛𝑢𝑢𝑓𝑓2)1/3 𝑣𝑣𝑝𝑝2Φp a (4) 
where nu is the number of spherical micelles in the cubic cell, f is the 
apolar volume fraction, υp is the volume of one PF127 molecule, Φp is the 
copolymer volume fraction in the system and a is the lattice parameter. The 
apolar volume fraction f, is given by: 
 𝑓𝑓 = 0.34Φp  (5) 
where 0.34 is the volume fraction of the PPO block in the PF127 
molecule (PPO weight fraction = 0.30). To convert the weight fractions of 
the components into volume fractions, the bulk densities of the copolymer 
(1.05 g/cm3), water and additives are used. The volume of one molecule is 
20000 Å3. The aggregation number of the micelles, Nagg, defined as the 
number of P127 molecules per micelle can be determined using: 
 
𝑁𝑁𝑎𝑎𝑎𝑎𝑎𝑎 = Φ𝑝𝑝  𝑎𝑎3𝑛𝑛𝑢𝑢𝑣𝑣𝑝𝑝  (6) 
In these equations nu = 4 for the unit cell of the face-centered lattice 
consisting of four micelles. 
Mortensen et al have shown that 20 % w/v PF127 gel may have face 
centered cubic (fcc) or body centered cubic (bcc) ordering depending on 
the proportion of diblock copolymer in the commercial triblock copolymer, 
with as-received samples forming fcc structured gels and purified samples 
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forming bcc gels [37]. Recently, Chaibundit et al found that with as-received 
PF 127, fcc structure is formed and with the addition of 10-30% ethanol, it 
changes to bcc structure [38]. Our results are in agreement with the 
reported findings; since all samples used in this study were prepared with 
the as-received PF127, a fcc structure was found. No significant variations 
in the nanostructure of PF127 gel were found after inclusion of GMs; indeed 
small differences in lattice parameter are within 5 % of error (Table 4). 
 
Table 4 PF127 volume fraction (Φp), apolar volume fraction (f), lattice parameter (a), 
interfacial area (ap) and aggregation number (Nagg) obtained from SAXS data for PF127 
gel, PF127 gel with LGAGM and LGluGM.  
Sample name PF127/W/GM 
Ratio Φp f 
Space 
group a (Å) ap(Å2) Nagg 
PF 20/80/0 0.192 0.065 Fm3m  294 ± 9 238 56 
PF+LGAGM 19.9/79.6/0.5 0.183 0.062 Fm3m  281 ± 12 244 45 
PF+LGluGM 19.9/79.6/0.5 0.183 0.062 Fm3m  281 ± 2 235 50 
 
This result implies that lysozyme, if any diffused from GMs and/or 
GMs themselves is/are not affecting significantly the discrete cubic LC 
structure of PF127 gel. 
 
3.3.6. In vitro release studies 
In vitro release studies performed on gelatin microspheres showed 
that both types of cross-linked microspheres showed burst release.  About 
51 % and 89 % of lysozyme was released in the first hour of release 
experiment in case of LGAGM and LGluGM, respectively. This difference in 
burst release of lysozyme from LGAGM and LGluGM could be attributed to 
the differences in degree of cross-linking of gelatin microspheres. Gelatin 
microspheres are known to swell in aqueous medium due to hydration. 
Glutaraldehyde and glucose forms bridges in polymeric chains of gelatin. 
Therefore, the extent of swelling process depends upon the degree of 
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cross-linking. If the degree of cross-linking is higher, more bridges are 
formed and microspheres swell less. Swelling of microspheres can cause 
increased mobility of encapsulated lysozyme, and hence diffusion from the 
microspheres into the release medium, occurs. Since glutaraldehyde has 
shown higher cross-linking density than glucose, lysozyme was released at 
higher rate in case of glucose crosslinked microspheres compared to 
glutaraldehyde crosslinked microspheres.  
 
   
 
Fig.3.7. In vitro release of lysozyme from (a) lysozyme loaded gelatin microspheres 
crosslinked by glutaraldehyde (LGAGM) and glucose (LGluGM); and (b) PF127 20 % w/v 
with lysozyme (PF), lysozyme loaded glutaraldehyde (PF + LGAGM) and glucose (PF + 
LGluGM) cross-linked gelatin microspheres  
 
The release of lysozyme from LGluGM and LGAGM suspended in 
PF127 gel was slower, in comparison also to lysozyme dissolved in PF127 
gel (Fig.3.7.b). PF127 gel released almost all the lysozyme in 5 hours, 
whereas the GMs suspended in PF127 gel could extend the release for 
another 1 hour. The reason for the slower release of lysozyme from the 
GMs suspended in PF127 gel could be the increased path required for 
lysozyme to pass through the micellar gel matrix before releasing into the 
buffer medium. It can be noted in Fig.3.7.b that during the initial 2 hours of 
release experiment, LGluGM suspended in PF127 gel released significantly 
more lysozyme (33 ± 0.34 %) in comparison to LGAGM suspended in 
0 50 100 150 200 250 300 350 400 450 500
0
10
20
30
40
50
60
70
80
90
100
110
120
%
 C
um
ul
at
ive
 ly
so
zy
m
e 
re
le
as
ed
Time (min)
 LGluGM
 LGAGM
0 50 100 150 200 250 300 350 400 450 500
0
10
20
30
40
50
60
70
80
90
100
110
120
%
 C
um
ul
at
ive
 ly
so
zy
m
e 
re
le
as
ed
Time (min)
 PF+LGluGM
 PF+LGAGM
 PF
)  
(a) (b) 
67 
 
PF127 gel (approximately 26 ± 4 %). This effect could be related to burst 
release of lysozyme from LGluGM (Fig.3.7.a). It is worth mentioning that 
after this initial burst release from LGluGM suspended in PF127 gel, the 
lysozyme was slowly released from both the GMs. 
Burst release of encapsulated drugs from microspheres is an 
unwanted phenomenon. To limit the burst release, some authors has 
suggested use of higher concentration of cross-linking agents. But, this has 
its inherent disadvantages, as cross-linking agents at high concentration 
will give rise higher toxicity or interact with the encapsulated drugs. 
 
3.4. Conclusions 
The results of this study allow to point out that the cross-linking of 
gelatin with glutaraldehyde and D-glucose produced two different cross-
linked structures. Although, the shape of microspheres was spherical in 
both the cases, the surface texture and size distribution was clearly distinct. 
The infrared spectroscopy analysis showed that the degree of cross-linking 
density was significantly different for the two types of microspheres 
obtained. Lysozyme, without losing its biological activity, was successfully 
loaded, although loading and encapsulation was significantly different for 
the two types of microspheres. The nanostructure of 20 % w/v PF127 gel 
was found to be a Fm3m type cubic discrete liquid crystal; that was not 
significantly modified upon gelatin microspheres addition.  PF127 gel has 
higher elastic modulus and complex viscosity than the microspheres in gel 
formulations. The suspension of GMs in PF127 gel allowed for a more 
sustained release of lysozyme. Finally, it should be remarked that the 
combination of these two different formulation systems into one can give 
more options to control the drug release.  
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4. ORDERED MESOPOROUS MATERIALS 
 
4.1. Introduction 
Ordered mesoporous materials (OMMs) have outstanding textural 
and structural features [1] that make them suitable hosts for bioactive 
molecules [2]. They have high surface area (about 1000 m2/g) a highly 
ordered, and hence a highly reproducible structure, with uniform pore size 
(2 – 50 nm) which is comparable with the diameter of many bio-
macromolecules. Most of previous works concerning the use of OMMs as 
sorbents for bio-macromolecules were aimed to stably immobilize an 
enzyme into the pores to obtain a stable and active biocatalyst [3-4] for 
potential industrial,[5-6] environmental,[7] or biosensing applications [8]. 
Innovative emerging applications are the use of OMMs in different 
nanomedicine topics, namely, carriers for the release of drugs and bioactive 
agents [9] and tissue engineering [10]. A drug delivery system is capable of 
releasing a carried bioactive agent in a specific location at a specific rate.  
The use of OMMs for biocatalysis or controlled release depends on 
the fact that the interaction between the macromolecule and the sorbent 
surface is strong or weak, respectively. Consequently, given a bioactive 
agent, the chemical surface of the sorbent material has an important effect 
on the strength of the interaction, and hence on the possible application [5]. 
In addition, it is relevant that OMMs surface can be easily modified by a 
wide number of suitable functionalizing agents[11-12] that allow for tailoring 
the sorbent surface to get the desired, weak or strong, interaction with the 
adsorbing molecule [13]. Moreover, the surface interaction can be 
modulated by the suitable choice of the pH,[3, 14] the ionic strength [14] 
and also the type of salt [15-16] of the adsorbing solution.  
SBA-15 and similar materials have been studied as delivery systems 
for different locations. Most researchers focused the attention in the oral 
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therapy, studying the controlled release of ibuprofen,[17] nimodipine,[18] 
itraconazole,[19] and many poorly soluble drugs [20]. Vallet-Regì and 
coworkers - taking advantage of the bioactive behavior of mesoporous 
silica, that can be covered by a layer of hydroxyapatyte[21-22] and thus 
used as bioceramics for bone tissue regeneration - deeply studied the local 
release of drugs for bones disease [12, 23-26]. Lopez et al. used ordered 
mesoporous silica for the storage and release of valproic acid and sodic 
phenytoin in the brain of rats [27].  
An important issue for the use of OMMs as drug delivery systems 
concerns their toxicity and biocompatibility. Hudson et al. found that 
subcutaneous injection of some OMMs in rats resulted in a general good 
biocompatibility as determined through histological investigations. In 
contrast, intra-peritoneal and intra-venous injections in mice caused death 
[28]. 
Another key point for the application of OMMs in drug delivery 
systems is the stability of the matrix in the releasing medium. Very recently 
Izquierdo-Barba et al. investigated the stability of SBA-15 like materials in 
selected aqueous media mimicking body fluids. They found that, although 
the mesoporous structure of SBA-15 was partially lost after 60 days in all 
tested media, organically modified SBA-15 samples exhibited a higher 
resistance to lixiviation [29].   
Here we report the characterization through TEM, SAXS, N2-
adsorption/desorption isotherms, ATR-FTIR, and potentiometric titrations of 
two different OMMs, namely: SBA-15 and MSE, and their use for the 
adsorption and the in vitro controlled release of a model protein - hen egg 
white lysozyme (Lyz) - in physiological conditions (pH = 7.4, t = 37°C). The 
effect of the different chemical surface and the adsorbing pH is 
investigated. Besides the structural features, it will be shown that the 
different material surface can affect both the loading amount and the 
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kinetics of the release. Finally, a comparison of the stability of the two 
matrices towards the lixiviation effect of the release medium is presented.  
 
4.2. Materials and methods 
4.2.1. Materials 
Chemicals for the synthesis and modification of OMMs, 
tetraethylorthosilicate (TEOS, 98%), pluronic copolymer 123 
(EO20PO70EO20), 1,2-bis(trimethoxysilyl)ethane (BTMSE) (96%) and 
buffer components, sodium hydrogencarbonate (99%), Na2HPO4 (99%), 
and NaH2PO4 (99%), were purchased from Sigma-Aldrich. Lysozyme from 
hen egg white (92717 U/mg) was purchased from Fluka. 
 
4.2.2. Characterization of OMMs and lysozyme 
SBA-15 mesoporous silica and MSE mesoporous organosilica were 
synthesized according to the methods reported in refs [30] and [31], 
respectively. SBA-15 and MSE were characterized with the following 
techniques. SAXS patterns were recorded (1200 s) with a S3-MICRO 
SWAXS camera system (HECUS X-ray Systems, Graz, Austria). Cu Kα 
radiation of wavelength 1.542 Å was provided by a GeniX X-ray generator, 
operating at 50 kV and 1 mA. A 1D-PSD-50 M system (HECUS X-ray 
Systems, Graz, Austria) containing 1024 channels of width 54.0 µm was 
used for detection of scattered X-rays in the small-angle region. 
Transmission electron microscopy (TEM) images were obtained on a JEOL 
100S microscope. Finely ground samples were placed directly onto 
formvar-coated electron microscopy nichel grids. Textural analysis was 
carried out on a Thermoquest-Sorptomatic 1990, by determining the N2 
adsorption/desorption isotherms at 77 K. Before analysis the sample was 
out-gassed overnight at 40 °C. The specific surface area, the total pore 
volume and the pore size distribution were assessed by the BET [32] and 
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BJH [33] methods respectively. ATR-FTIR studies were conducted with a 
Bruker Tensor 27 spectrophotometer equipped diamond-ATR accessory 
and DTGS (deuteriotriglycine sulphate) detector. A number of 128 scans at 
resolution of 4 cm-1 were averaged from wavenumber 4000 to 400 cm-1. 
The Opus spectroscopic software was used for data handling. Surface 
charge densities of SBA-15 and MSE were determined through 
potentiometric titrations according to the procedure reported in ref [15]. The 
theoretical titration curve of lysozyme and the corresponding theoretical pI 
were obtained through PROPKA 2.0 software [34-35]. Lysozyme images in 
Fig.4.5.a-d were made with VMD software support. VMD is developed with 
NIH support by the Theoretical and Computational Biophysics group at the 
Beckman Institute, University of Illinois at Urbana-Champaign. 
 
4.2.3. Loading of lysozyme.  
To load lysozyme on SBA-15 and MSE, 0.2 g of the mesoporous 
sample were suspended in 10 mL of aqueous solution of lysozyme (10 
mg/mL) prepared in 10 mM phosphate buffer pH 7.0 or 10 mM sodium 
hydrogen carbonate buffer at pH 9.6, and soaked for 96 hours with shaking 
at 100 rpm and 37°C. The concentration of lysozyme was measured by UV 
spectrophotometer at a wavelength of 280 nm. The amount of lysozyme 
loaded onto the samples was determined according to the change of 
concentration before and after soaking. After loading, the powders were 
quickly and thoroughly washed with water and dried under vacuum. The 
loading of lysozyme - LLyz (mg/g) – on mesoporous material was 
calculated according the following formula: 
 
s
wwri
m
VLysozVLysozVLysozloading ][][][ −−=
 
 (1) 
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where, [Lysozi] is the protein concentration in the initial solution 
(mglysozyme/mLsolution) method; [Lysozr] is the residual concentration of protein 
in solution (mglysozyme/mLsolution); [Lysozw] is the protein concentration of 
remained in the washing solution (mglysozyme/mLsolution); V is the volume of 
the lysozyme solution (mL), Vw is the washings volume (mL), and ms is the 
mass of support (g). 
 
4.2.4. In vitro lysozyme release studies  
The in vitro lysozyme release from the loaded materials was studied 
in phosphate buffer solution (PBS) (pH 7.4 , 50 mM), by suspending 50 mg 
of lysozyme loaded SBA-15 (or MSE) in 100 mL of PBS and maintained at 
37°C in an orbital shaker (100 rpm). These experimental conditions were 
chosen according to what previously reported [36]. At fixed time intervals, 5 
mL of the releasing solution was withdrawn, and an identical volume of a 
fresh PBS solution was added to maintain sink conditions. Lysozyme 
concentration in each of the collected samples was measured at 280 nm 
using a Cary UV-Vis spectrophotometer. The amount of lysozyme released 
at time t, Mt, was determined from the appropriate calibration line (with an 
absorption coefficient ε280 = 2.803 ml mg−1 cm−1). The total amount of 
lysozyme incorporated in the material was taken as M0, thus, the 
percentage of the lysozyme released was expressed as Mt/M0(%). An 
exponential decay model was used for the fitting of the experimental data 
according to ref. [37].   
 )1( 1
0
tkt eA
M
M −−=  (2) 
where, A is the maximal mass percentage released and k1 is the 
release rate constant. The correlation coefficient (r) was calculated to 
evaluate the accuracy of the fitting procedure. 
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4.3. Results and discussion 
4.3.1. OMMs and protein characterization  
4.3.1.1. OMMs characterization  
The two investigated OMMs present a different surface from the 
chemical point of view. SBA-15 is a silica-based mesoporous structure, 
hence its surface is constituted by silanols. MSE is a periodic mesoporous 
organosilica in whose synthesis silicon atoms are alternatively connected 
by means of -Si-O-Si- and -Si-CH2-CH2-Si- groups. The presence of the 
methylene groups confers a higher hydrophobic character to the material 
compared to SBA-15. The different chemical composition of OMMs was 
qualitatively confirmed by ATR-FTIR spectroscopy (Fig.4.1).  
 
Fig.4.1. ATR-FTIR spectra of original OMMs after lysozyme loading (pH 7 and 9.6) and 
release (T = 37 °C and pH 7.4). 
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Both materials present an intense band at 1070 cm-1 due to Si-O 
stretching, one less intense at 450 cm-1 due to Si-O-Si bending, and also a 
band at 950 cm-1 due to silanols. In addition, MSE shows bands due 
stretching vibrations at 2916 cm-1 (νC-H) and 1645 cm-1 (νC-C), and to 
bending vibrations (δC-H) at 1412 and 1271 cm-1, respectively. 
 
 
Fig.4.2. TEM images of OMMs. (a,b) original SBA-15; (c) SBA-15 sample after Lyz 
release; (d,e) orginal MSE; (f) MSE sample after Lyz release. 
 
Fig.4.2 shows the TEM micrographs of the two materials. For SBA-
15 the side view (Fig.4.2.a) shows that the material is constituted by 
cylindrical channels, and the top view (Fig.4.2.b) shows the ordered 
hexagonal array of the pores. MSE particles (Fig.4.2d and 4.2.e) were less 
regular than those of SBA-15 but the ordered hexagonal structure can 
clearly be seen also in this case. SAXS analysis carried out on OMMs 
shows the typical pattern of a hexagonal phase where an intense peak due 
to (1 0 0) plane and other two less intense peaks due to (1 1 0) and (2 0 0) 
planes occur (Fig.4.3). From SAXS measurements the lattice spacing (a) of 
(a) 
(f) (e) (d) 
(c) (b) 
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the two structures was determined, this was 112 Å for SBA-15 and 119 Å 
for MSE (Table 1). 
 
Fig.4.3. SAXS Pattern of OMMs after lysozyme loading (at pH 7.0 and 9.6) and after in 
vitro release (pH 7.4, T = 37 °C) 
 
Table 1 Characterization of OMMs Obtained Through N2-Adsorption/Desorption Isotherms 
and SAXS. 
  SBET a Vp b dBJH c dBJH d a e 
(m2/g) (cm3/g) (Å) (Å) (Å) 
SBA-15 718 1.2 86 65 112 
MSE 1752 2.2 76 58 119 
 
a Specific surface area calculated by the BET method; b cumulative pore volume; c pore 
diameter calculated by applying BJH method to the data of the adsorption branch; c pore 
diameter calculated by applying BJH method to the data of the desorption branch; d lattice 
parameter calculated by the equation a=2d100/√3, where d100 is the spacing of the (1 0 0) 
plane of hexagonal (p6mm) array of pores.  
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The OMMs were then characterized through N2 
adsorption/desorption isotherms. Both samples show a type IV isotherm, 
with a steep increase typical of mesoporous solids at a relative pressure 
around 0.70-0.75 (Fig.4.4.a). The presence of a hysteresis cycle, defined 
by IUPAC as H1, is closely associated with channel-like mesopores [38]. 
Table 1 reports the specific surface area (SBET), the total pore volume (Vp), 
calculated by BET method [32]. SBA-15 had a SBET = 718m2/g, a Vp= 2.1 
cm3/g; a very high value of surface area, SBET = 1752 m2/g and Vp= 2.2 
cm3/g was obtained for MSE. The pore size distribution (dBJH) of the 
materials was calculated from both adsorption and desorption branches of 
the isotherms through the BJH model. A dBJH = 86 Å (adsorption branch) 
and dBJH = 65 Å were obtained for SBA-15, whereas a dBJH = 76 Å and dBJH 
= 58 Å were obtained for MSE. Although the BJH model is known to 
underestimate the diameter of the mesopores, it is still the most used 
calculation method because software using more accurate models (i.e., 
NLDFT) [39] is not easily available. 
   
Fig.4.4. Characterization of SBA-15 and MSE. (a) N2-adsorption/desorption isotherms; (b) 
Surface charge density versus pH. 
 
The last characterization of the ordered mesoporous materials was 
the determination of surface charge density as a function of pH that was 
carried out through potentiometric titration; results are displayed in 
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Fig.4.4.b. SBA-15 surface was practically neutral from pH 3 to pH 5-6, 
whereas at higher pH it became negatively charged due to the acidic 
behavior of surface silanols. According to its hydrophobic nature, the 
surface charge density of MSE was practically zero up to pH 9, and then 
becoming only slightly negative charged at basic pH (> 8) values.  
 
4.3.1.2. Protein characterization 
The model protein used for this work was hen egg white lysozyme 
(E.C.3.1.1.17). Lysozyme belongs to the family of hydrolases and its 
biological function is the hydrolysis of polysaccharides constituting bacterial 
cell wall. It is a globular protein consisting of 129 residues (MW=14.3 kDa) 
in the form of five α-helices, three antiparallel β-sheets and a large number 
of random coils and β-turns. Four disulfide bridges are responsible for the 
stabilization of the structure of the protein that displays an ellipsoidal shape 
with a large cleft acting as active site. Its dimensions (19×25×43 Å) allows 
for the adsorption into the pores of both investigated materials. 
As shown below, the adsorption and the release processes of Lyz 
are strongly dependent on the intermolecular interactions between the 
protein and OMMs surfaces. Hence, the amino acid composition of Lyz, 
shown in Fig.4.5, plays a fundamental role. Charged amino acids are 
mainly located on the protein surface, the basic amino acids being more 
abundant (Fig.4.5.a) than the acidics (Fig.4.5.b). Uncharged amino acids 
are more abundant than those charged: non polar residues are less 
exposed at the hydrophilic external surface with respect to polar amino 
acids as illustrated in Fig.4.5.c, and 4.5.d. Fig.4.5.e reports the number of 
different types of amino acids (basic, acidic, polar, and non polar). The 
presence of a higher number of basic residues with respect to acidic 
residues is reflected by the high isoelectric point of the protein (pI ~ 11), 
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and by the theoretical protein charge as a function of pH reported in 
Fig.4.5.f.  
    
Basic 18 Acidic 9 Polar 45 
Non 
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HIS 1 
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PRO 2 
      
VAL 6 
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Fig.4.5. Hen Egg Whyte Lysozyme characterization by taking the amino acid 
composition available at protein data bank (1LYZ.pdb). Structural representation of the 
amino acid residues by using VMD (video molecular dynamics) of (a) basic amino acids; 
(b) acidic amino acids; (c) polar (uncharged) amino acids; (d) non polar amino acids. (e) 
Number of amino acid of different classes ; (f) theoretical titration curve of lysozyme 
obtained through PROPKA 2.0 software; (g) ATR-FTIR spectrum. 
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4.3.2. Adsorption of lysozyme on OMMs 
The adsorption of Lyz on the two OMMs matrices was carried out by 
suspending a weighed amount of them in a Lyz solution at 37°C. The effect 
of pH was also investigated by dissolving lysozyme powder in two different 
buffer solutions at pH 7.0 and 9.6. The higher pH was chosen because the 
maximal loading is usually obtained in proximity of the protein isoelectric 
point [3, 40]. Unfortunately we could not use pH 11 since, at a so high pH, 
silica becomes soluble in the solution. Hence, pH 9.6 was chosen as the 
best compromise between these two exigencies. Lyz adsorption was 
determined through UV spectroscopy (λmax= 280 nm), and loading was 
calculated, according to eq. (1), as the difference between protein 
concentration in the buffer solution at the beginning and at the end of the 
adsorption process.  
The adsorption of lysozyme on the OMMs was also qualitatively 
demonstrated by means of ATR-FTIR spectroscopy. FTIR spectrum of free 
lysozyme shows the two typical bands of proteins namely, amide I at 1643 
cm-1, and amide II at 1522 cm-1 (Fig.4.5.g). The same bands, although a bit 
shifted in frequency (amide I: 1653 cm-1; amide II: 1537 cm-1), occur in the 
spectra of the Lyz-loaded OMMs as shown in Fig.4.1. 
The experimental results for Lyz loading on the OMMs at pH 7 and 
9.6 are reported in Table 2. Lyz loading at pH 7.0 was 587 mg/g for SBA-15 
and 450 mg/g for MSE, whereas at pH 9.6 it was 646 mg/g for SBA-15 and 
500 mg/g for MSE. These results deserve some comments. Let us take into 
account the experimental surface charge densities of OMMs at pH 7.0 and 
9.6 (Table 2) and lysozyme theoretical charge (+8.0 at pH 7.0, and +3.7 at 
pH 9.6) taken by the graph shown in Fig.4.4.b.  
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Table 2 Lysozyme Loading and Release parameters on OMMs and their surface charge 
densities (σ) at the adsorption pH. 
OMM Adsorp- σ LLyza Ab k1c Rd aadse 
 (Å) 
arel f  
(Å) tion pH (charges/
nm2) 
(mg/g) (%) (Χ 10-6 
s-1) 
SBA-15 7 -1.6 587±63 43±2 5±0.8 0.986 116 121 
SBA-15 9.6 -12.0 646±34 46±2 14±3 0.958 117 119 
MSE 7 -0.2 450±48 17.2±0.3 139±28 0.990 119 119 
MSE 9.6 -0.7 500±50 28.6±0.5 81±8  0.989 119 119 
 
a Loading of adsorbed lysozyme  b Maximal amount of released lysozyme; c release rate 
constant (n=2, data is represented as avg±SD) t; d correlation coefficient; e lattice 
parameter after lysozyme adsorption; f Lattice parameter after lysozyme release. 
 
Electrostatic forces seem to be the leading interactions in the 
adsorption of positively charged Lyz on negatively charged SBA-15. At pH 
9.6 a higher loading is obtained due to the lower electrostatic repulsion 
among lysozyme molecules [3]. If electrostatics was the only type of 
intermolecular interaction involved the low charge carried by MSE at both 
pH values, due to its hydrophobic character, would lead to a very low 
loading of lysozyme. Nevertheless, although lower than that of SBA-15, 
MSE reached a quite high loading likely due to the establishment and the 
action of non electrostatic forces (i.e. van der Waals, London) between 
hydrophobic groups at MSE and lysozyme surfaces. 
Besides, the ionic strength of the adsorbing solution and of the 
release medium can have important effects. Hudson et al. showed that 
increasing the ionic strength disfavored the adsorption of cytochrome c and 
xylanase on SBA-15, whereas an initial decrease followed by an increase 
was observed for the same enzyme on MSE [14]. Essa et al. showed that 
the effect of ionic strength is not univocal for a protein/adsorbent pair (i.e., 
myoglobin/SBA-15), but different results are obtained at different adsorbing 
pHs.39 Very recently, we found that lysozyme adsorption on functionalized 
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SBA-15 depends not only on the ionic strength of the solution but also on 
the type of salt. We could order the effectiveness of anions and cations on 
promoting protein adsorption according to the Hofmeister series [41]. The 
involved phenomena are complicated but can be easily explained invoking 
Collins’ empirical law of matching water affinities [42]. Briefly, ionic strength 
can either promote or disfavor adsorption, depending on the nature 
(dispersion and/or electrostatic) of protein-adsorbent interactions. 
Concerning the textural properties, pore size is an important parameter that 
can affect protein adsorption. Serra et al. investigated the immobilization of 
Candida antarctica lipase B on OMMs having different pore sizes [38]. They 
found that, during the adsorption process, diffusion limitations occurred 
when the pore size was similar to the enzyme size, but these disappeared 
when the pore diameter was around twice the largest enzyme dimension. 
On the basis of these findings and OMM’s pore size (Table 1), we would 
expect an easier adsorption due to faster mass diffusion of lysozyme 
(dimensions: 19 × 25 × 43 Å) in SBA-15 compared to that in MSE. In any 
case, because we carried out the adsorption process for a long time (96 h), 
even a very slow diffusion should take place. Concerning the other textural 
properties, the surface area and the pore volume are higher for MSE than 
that for SBA-15 and should lead to a higher loading for the former 
compared to the latter. Exactly the opposite occurs (Table 2), likely 
because enzyme molecules occupy a small fraction of the total volume and 
surface [38]. It can be substantially concluded that the obtained loadings 
are mainly due to surface properties (charges and hydrophobic/ hydrophilic 
character) rather than to textural properties. 
 
4.3.3. Release of lysozyme  
In vitro release of Lyz from OMMs was carried out, for about 30 
days, in a phosphate buffer solution at pH 7.4 and 37°C to mimick 
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physiological conditions. Samples were withdrawn at fixed times and 
analyzed by UV spectroscopy. Experimental results of release, shown in 
Fig.4.6, were fitted by means of eq. (2) that allowed determining the 
maximal mass percentage released A, and the release rate constant k1. 
These data are listed in Table 2. A very different behavior between MSE 
and SBA-15, also modulated by the adsorption pH, was observed. SBA-15 
is the material that releases the highest percentage of Lyz (ApH 9.6 = 46%; 
ApH 7.0 = 43%) followed by MSE (ApH 9.6 = 28.6%; ApH 7.0 = 17.2%). The 
maximal amount of release was higher for samples where Lyz was 
adsorbed at pH 9.6 both for SBA-15 and MSE. 
Table 2 reports also the kinetic release constants k1 as determined 
by the fitting procedure of experimental data. Lyz molecules adsorbed on 
MSE were released faster (k1 = 139 µs-1 at pH 7.0; k1 = 81 µs-1 at pH 9.6) 
than those adsorbed on SBA-15 (k1 = 5 µs-1 at pH 7.0; k1 = 14 µs-1 at pH 
9.6).  
 
Fig.4.6. Release of lysozyme from OMMs. (pH 7.4, t=37°C) 
 
The fact that more than 50% of adsorbed lysozyme was not released 
is not surprising. The reason is evidently due to the strength of the 
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interactions between the surfaces of the protein and the hosting material. 
Indeed, there are several works in which enzymes are immobilized by 
physical adsorption for biocatalytic purposes [4, 8, 14, 43-44]. In those 
works, desorption is an unwanted effect that is different than what is 
needed for release studies. The amount of lysozyme released depends on 
the choice of the protein-adsorbent pair. Very recently, Nieto et al. found 
that the amount of released BSA was strongly dependent on the chemical 
groups present on the SBA-15 surface [13]. Here, although electrostatic 
interactions lead to a higher Lyz loading with SBA-15, this kind of 
interaction is not able to retain the protein when in contact with the 
releasing medium. A rather burst release occurs. On the other hand, 
nonelectrostatic forces, responsible for lysozyme adsorption on the more 
hydrophobic MSE, are likely to adsorb more strongly than protein molecules 
that, hence, are less available for release. There is also a modulation effect 
due to the adsorption pH that increases both the loading and release as it 
approaches the isoelectric point of the protein. The higher release rates 
observed for MSE matrixes at both pHs, compared to SBA-15, are likely to 
be due to the high burst release of Lyz adsorbed on the outer surface of the 
MSE particles. Nevertheless, it can be remarked that burst release from 
MSE occurs at a much lower extent (and for a much shorter time) than that 
from SBA-15. Another effect, not investigated here, might be obtained with 
other release medium. In the literature, different media having the same pH 
but higher ionic strength (i.e., 0.9% NaCl)13 or SBF (simulated body fluid) 
have been used.44 We may expect that a change in the ionic strength, and 
also the ionic composition, of the release medium would strongly affect both 
the release trends and the material stability [29]. For example, if the 
lysozyme-SBA-15 interaction is mainly based on electrostatics, we might 
expect an increased release at higher ionic strength due to salt adsorption 
at the protein and adsorbent charged groups. The opposite effect would be 
88 
 
expected for MSE due to the hydrophobic interaction with lysozyme. In any 
case, the effects observed here, due to different chemical composition of 
the adsorbent and a different pH of adsorption, are quite remarkable since 
they affect the amount and the rate of lysozyme release. 
 
4.3.4. OMMs stability in the release medium  
The stability of OMM samples after 32 days of in vitro release in the 
release medium (pH 7.4 and 37 °C) was studied through FTIR, SAXS, and 
TEM. FTIR analysis (Fig.4.1) shows that there is no appreciable change in 
the OMM spectra after release with respect to those after lysozyme loading 
at the two pH values (7.0 and 9.6). The amide I and amide II bands are still 
present according to the fact that a substantial amount of lysozyme 
molecules is still adsorbed in the matrixes. In fact, looking at TEM 
micrographs (Fig.4.2c and f), it appears that the ordered structure of SBA-
15 is partially destroyed due to the lixiviation action of the physiological 
medium. Effects at much lower extent are observed for MSE, which seems 
to be more resistant toward lixiviation. A similar result was found by 
Izquierdo-Barba et al., who focused on the in vitro stability of SBA-15 in 
different physiological media [29]. Matrix lixiviation observed by TEM was 
furthermore confirmed by SAXS measurements. Fig.4.3 shows that a 
significant decrease of the intensity of the second- and third-order 
diffraction peaks occurs after Lyz release experiments. This could be due to 
the partial loss of the ordered hexagonal structure. This intensity loss was 
less important for MSE, in agreement with the lower degree of dissolution of 
the matrix observed in TEM pictures. Moreover, the comparison between 
the lattice parameters, obtained from SAXS analysis, reported in Tables 1 
and 2, points out an interesting result; the original SBA-15 has a lattice 
parameter of 112 Å that increases to 116 Å after Lyz adsorption at pH 7 
(117 Å at pH 9.6) and to 121 Å after Lyz release (119 Å at pH 9.6). On the 
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contrary, MSE retains a constant lattice parameter of 119 Å during all steps 
of the study, thus confirming its higher resistance to the lixiviating action of 
both the adsorption and the release media. From these results, besides the 
initial burst release due to Lyz adsorbed on the outer surface of both 
OMMs, a different mechanism of lysozyme release from the two matrixes 
can be suggested. Indeed, in the case of SBA-15, Lyz release is enhanced 
by the swelling of the channels due to the nucleophilic attack of water to 
siloxane groups, whereas for MSE, release is mainly due to the diffusion of 
Lyz molecules outside of the pores. 
As a matter of fact, Izquierdo-Barba et al. found that the 
functionalization of the SBA-15 surface was a good procedure to enhance 
the structural stability [29]. Here, the use of a more hydrophobic structure, 
without the need of any post synthesis functionalization, allowed a similar 
result to be reached. 
 
4.4. Conclusions 
The present work focuses on two OMMs having similar structure and 
texture but different chemical composition and surface properties. These 
OMMs can be used for the adsorption and the release of lysozyme, a 
therapeutic protein. Among others, a peculiar advantage of these OMMs is 
the narrow range of pore sizes that constitutes the crucial size-selective 
parameter to address guest molecules adsorption. The use of BTMSE as 
the organosilica precursor produces the MSE OMM that shows a hexagonal 
matrix as well as SBA-15, but with a slightly smaller pore size and larger 
surface area. It should be remarked that the small reduction of the pore size 
does not prevent the adsorption of protein molecules whose maximal 
dimension is 43 Å. Indeed, this fact does not modify Lyz loading 
significantly, although the very different nature of the surface, in terms of 
surface charge, also implies different types of host-guest (surface-protein) 
90 
 
interactions. The van der Waals interactions, mainly involved in the 
adsorption/release process at the Lyz/MSE interface, seem to produce 
stronger protein binding than the electrostatic forces that dominate the 
Lyz/SBA-15 interface. As a matter of fact, this strong protein binding in the 
Lyz-loaded MSE matrix decreases both the time over which burst release 
occurs and the released amount of protein significantly. It is remarkable that 
a short burst release, in all cases, suggests that only a small amount of 
adsorbed protein is located on the outer surface of the OMM particle. 
Another very significant parameter that affects both adsorption and release 
is the pH of the adsorbing solution. This allows for a potential modulation of 
the global performance, in terms of the loaded amount of protein, and the 
rate of release. In other words, a personalized sustained release may be 
produced. Another important consideration concerns the longer shelf life in 
the physiological medium observed for MSE compared to that for SBA-15. 
Silica materials tend to dissolve in biological fluids, and this can develop 
toxicity when accumulation above certain concentrations occurs [28]. 
Hence, if a silica-based drug delivery system has to be projected in view of 
possible innovative applications (cf. protein drug delivery) and 
performances (cf. sustained release), it is relevant to introduce structural 
features that can prolong the shelf life and attenuate dangerous, though not 
fatal, side effects.  
Finally, the last comment in favor of the MSE OMM being used as a 
sustained drug release carrier is given by the relatively easy and 
reproducible synthesis; this is a peculiar feature of all OMMs that does not 
involve any postsynthesis functionalization step. 
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5. MONOOLEIN BASED FORMULATIONS FOR CAFFEINE 
 
5.1. Introduction 
One of the successful and novel area of research in drug delivery that 
aims to enhance therapeutic efficacy, bioavailability and avoid adverse 
effects of the drugs is transdermal/topical drug delivery [1]. Different 
approaches such as iontophoresis [2], sonophoresis [3], transdermal gels 
[4]  nanoemulsions [5] and chemical enhancers [6] have been used to 
enhance skin permeation and bioavailability of drugs. Surfactants, a 
category of chemical enhancers, can form liquid crystalline (LC) phases in 
the presence of water. Lyotropic LC formulations based upon use of 
biocompatible lipids have been studied for drug delivery of a wide number 
of small molecules as well as proteins and peptides [7]. Emulsions 
stabilized by LC phases are one of the most promising approaches for 
transdermal/topical delivery of drugs and cosmetics. It presents many 
advantages over conventional creams and ointments such as higher 
storage stability, good production feasibility, higher thermodynamic stability 
and absence of organic solvents [8-12].  
LC phases of monoolein present interesting properties for drug 
delivery system across the skin and mucosa. Monoolein is a biocompatible 
and bioadhesive chemical enhancer and has the ability to incorporate 
compounds independently of their solubility. It can protect drugs from 
physical and enzymatic degradation and sustain their delivery [13]. It is 
non-irritant, non-toxic and safe to the skin and fall under generally 
recognized as safe (GRAS) category [14]. It is useful for transdermal/topical 
drug delivery since it promotes ceramide extraction and enhancement 
of lipid fluidity in the stratum corneum region of the skin [15]. Moreover, it 
swells in water and depending on water content and temperature several 
LC phases can be formed, including lamellar, bicontinuous cubic and 
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hexagonal phases. The lamellar and bicontinuous cubic phases 
of monoolein and water are formed at room temperature, and have been 
shown to accommodate and sustain the release of drugs with various 
physical and chemical properties [7, 16-17]. The reverse hexagonal phase 
of monoolein and water is obtained only at high temperatures, unless a 
third nonpolar component (e.g. triglycerides or oleic acid) is added to the 
system [18]. Also this phase presents the ability to sustain the delivery of 
incorporated compounds [19]. Earlier, it has been showed that an emulsion 
prepared by dispersing water in the LC medium shows a long-term shelf life 
[11]. The stability of such a system towards phase separation is high. The 
use of thermodynamically stable LC phases, preferentially lamellar or 
hexagonal microstructure, allows the dispersion of many types of liquids 
[11]. 
 
Fig.5.1.Chemical structure of caffeine 
 
Model small molecular weight (194.19 Da) water soluble (21.7 mg/ml) 
drug caffeine is often used in the release kinetics experiments from 
emulsions and microemulsions [20-22]. The chemical structure of caffeine 
is represented in Fig.5.1. It is non-irritant and compatible with lipidic 
membranes. It has several therapeutic and cosmetic applications. It has 
been investigated in the treatment of neonatal apnea [23], in the prevention 
of neurodegenerative disorders [24], in the treatment of skin cancer [25] 
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and in the anti-cellulite activity by stimulation of fat metabolism [26]. Several 
commercially available topical formulations contain about 3% caffeine [20].   
The aim of this study was to investigate the microstructure and 
physico-chemical properties of W/O emulsion, lamellar, reverse hexagonal, 
and bicontinuous cubic LC formulations prepared with primarily monoolein 
and caffeine solution (CS). In order to prepare reverse hexagonal LC 
formulations and emulsions stabilized by liquid crystals, triolein was used 
as non-polar component. The emulsion and different LC phases were 
obtained according to the monoolein-water phase diagram and ternary 
phase diagram of monoolein, triolein and water [11, 27]. In vitro release 
properties of caffeine from these formulations were investigated.  
 
5.2. Materials and methods 
5.2.1. Materials 
Monoolein (MO) (98.1 wt.%) was kindly provided by Danisco 
Ingredients, Brabrand, Denmark. Triolein (TRI) with technical purity of 65 
wt.% (this reagent contains also 1,3- and 1,2-diglycerides, monoglycerides; 
the fatty acid chain composition is 90 wt.% as oleic acid and 10 wt.% as 
linoleic acid), was from Sigma. Caffeine (99 wt.%) was obtained from 
Sigma. Distilled water (W), passed through a Milli-Q water purification 
system (Millipore), and deuterated water from Fluka were used to prepare 
the samples. 
 
5.2.1. Preparation of formulations 
The formulations were prepared according to the components and 
composition given in Table 1.  Caffeine solution (CS) used for preparing the 
formulations was prepared with the fixed concentration of 10 mg/ml in water 
(W) or deuterated water (D2O). The samples for NMR experiments were 
prepared using D2O instead of W. 
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Table 1 Components and composition of formulation. 
Formulation Composition Ratio 
Amount of caffeine 
(mg)/g of formulation 
I MO/TRI/W/CS 63/11/19/7 0.7 
II MO/TRI/CS 69/11/20 2.0 
III MO/CS 85/15 1.5 
IV MO/CS 70/30 3.0 
V MO/TRI/CS 80/11/9 0.9 
        
For preparation of formulation I, MO (3.77 g) was melted in a glass 
test tube (80 ml Duran Schott, Germany) at about 40 °C and TRI (0.66 g) 
was added subsequently. A small amount (approximately 200 µl) of W was 
added to this mixture and vortexing was done at approximately 2500 rpm 
for about 5 min. This was repeated till the total volume of W added 
becomes 1110 µl. This sample was centrifuged for about 20 minutes at 
2000 rpm. It was kept in incubator at 25 °C overnight to achieve equilibrium. 
A small amount (approximately 200 µl) of CS (10 mg/ml) was added to the 
LC phases and again vortexing was done. A total of 450 µl of CS was 
added and vortexing was done each time. Finally sample was centrifuged 
at 1000 rpm for 10 minutes in order to settle down the emulsion stuck on 
the wall of glass tube. Formulation II was prepared similarly using CS 
instead of W for the formation of LC phase. For the preparation of 
formulation III and IV, CS was mixed with monoolein according to the 
composition mentioned in Table 1. 
   
5.2.2. Polarized light microscopy (PLM) 
 The anisotropic LC phases were observed by optical microscopy 
(Zeiss Axioplan 2) in polarized light at 25 ± 1 °C. The obtained patterns 
were compared with the typical textures of other surfactants [28]. 
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5.2.3. Nuclear Magnetic Resonance (NMR) 
2H NMR measurements were performed by a Bruker Avance 7.05 T 
spectrometer at the operating frequency of 300 MHz at 25 °C. A standard 
variable temperature control unit (with an accuracy of 0.5 °C) was used. 2H 
NMR spectra were periodically recorded, without lock, to verify the 
achievement of equilibrium and to characterize the LC microstructure in 
mono- or multiphase samples.  
Nuclei with a spin quantum number I ≥ 1, such as 14N or 2H, have an 
electric quadrupolar moment that can interact with nonzero net electric field 
gradients giving multiple resonance of 2I peaks, which in the case of 
oriented anisotropic LC phases are separated by the splitting: 
 ∆𝜈𝜈𝑞𝑞 = (3 𝑓𝑓⁄ )𝑃𝑃𝑜𝑜𝑖𝑖𝑆𝑆𝑜𝑜  (1) 
where m = 4 and m = 8 apply for the lamellar and hexagonal phase, 
respectively, Pb is the fraction of the observed nucleus in the bound state, Χ 
is the quadrupolar coupling constant, and Sb = ½(3cos2νD - 1) is the order 
parameter related to the average time orientation (νD) of the nucleus with 
respect to the surfactant chain axis. For water molecules, Pb is linearly 
dependent on the surfactant/water (S/W) molar ratio and thus equation 1 
can be rewritten as 
 Δ𝜈𝜈𝑞𝑞 = (3 𝑓𝑓)⁄ 𝑛𝑛𝑜𝑜(𝑆𝑆 𝑊𝑊⁄ )𝑖𝑖𝑆𝑆𝑜𝑜  (2) 
where nb is the number of bound water molecules per polar head. 
The inner and outer peaks correspond to the nuclei orientations at 90° and 
0°. Each sample was left for 30 min in the NMR probe to ensure thermal 
equilibrium and alignment in the magnetic field before recording the spectra 
at 25 °C.  
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5.2.3. SAXS experiments 
Small-angle X-ray scattering (SAXS) diffraction patterns were 
recorded with a S3-MICRO SWAXS camera system (HECUS X-ray 
Systems, Graz, Austria). Cu Kα radiation of wavelength 1.542 Å was 
provided by a GeniX X-ray generator, operating at 50 kV and 1 mA. A 1D-
PSD-50M system (HECUS X-ray system) containing 1024 channels of 
width 54 μm was used for detection of scattered X-rays in the small-angle 
region. The working q-range (Å−1) was 0.003 ≤ q ≤ 0.6, where q = 4πsin (θ) 
λ−1 is the modulus of the scattering wave vector. To minimize scattering 
from air, the camera volume was kept under vacuum during the 
measurements. Silver behenate (CH3-(CH2)20-COOAg) with a d spacing 
value of 58.38 Å was used as a standard to calibrate the angular scale of 
the measured intensity. The diffraction patterns were first recorded in 
increasing order of temperature i.e. 25, 32 and 37 ºC and latter it was 
decreased to original sample temperature of 25 ºC to study the effect of 
temperature on the stability of LC phases. A PC-controlled Peltier element 
was used for temperature stabilization and control of the sample. A few 
milligrams of the sample were enclosed in a stainless steel sample holder 
using a polymeric sheet (Bratfolie, Kalle) window. The distance between the 
sample and detector was 254 mm. The lattice parameter (a) of the different 
LC phases was determined using the relation d = 2π/q = α/(h2 +k2 +l2)1/2 
from linear fits of the plots of q versus (h2 +k2 +l2)1/2, where q is the 
measured peak position and h, k, and l are the Miller indices. The lattice 
parameters are represented as mean ± standard deviation. Standard 
deviation was calculated by considering lattice parameter values for all the 
major peaks.  
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5.2.4. In vitro release studies 
Caffeine release from W/O emulsion and LC formulations was 
monitored using Franz diffusion cells. Membrane diffusion was performed 
on cellulose membrane (MS CA membrane filter, pore size 0.45 μm, 
Membrane Solutions, USA). Test material was applied to 
the membrane with a glass rod and a dose (1000 mg) of formulation was 
applied and the cells were covered with parafilm in order to avoid water 
evaporation.  The receptor fluid phosphate buffer pH 7.4 (50 mM) was 
stirred constantly and maintained at 37 °C. Sodium azide (0.02% w/v) was 
added to the receptor fluid to prevent microbial growth. Membranes were 
allowed to equilibrate with the receptor phase for 2h before charging each 
donor compartment with the formulations. The sampling times investigated 
were 1, 2, 3, 4, 6, 8 and 24 h. Samples (2 ml) of receptor phase were 
withdrawn and each sample removed was replaced by an equal volume of 
fresh receptor phase. The diffusion experiment was performed 3 times for 
each formulation except if noted differently. 
 
5.3. Results and discussion 
5.3.1. Phase behaviour 
Caffeine release from W/O emulsion and LC formulations was 
monitored using Franz diffusion cells. Membrane diffusion was performed 
on cellulose membrane (MS CA membrane filter, pore size 0.45 μm, 
Membrane Solutions, USA). Test material was applied to 
the membrane with a glass rod and a dose (1000 mg) of formulation was 
applied and the cells were covered with parafilm in order to avoid water 
evaporation.  The receptor fluid phosphate buffer pH 7.4 (50 mM) was 
stirred constantly and maintained at 37 °C. Sodium azide (0.02% w/v) was 
added to the receptor fluid to prevent microbial growth. Membranes were 
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allowed to equilibrate with the receptor phase for 2h before charging each 
donor compartment with the formulations. The sampling times investigated 
were 1, 2, 3, 4, 6, 8 and 24 h. Samples (2 ml) of receptor phase were 
withdrawn and each sample removed was replaced by an equal volume of 
fresh receptor phase. The diffusion experiment was performed 3 times for 
each formulation except if noted differently. 
 
Fig.5.2. (a) Phase diagram for MO/W system in the 0–120 °C temperature and 0–50% 
(w/w) water composition range, and (b) Schematic and phase diagram of the ternary 
system of MO/TRI/W at 25 °C. 
 
5.3.2. Polarized light microscopy 
The preliminary information about the phase behaviour of the 
emulsion and LC samples with CS instead of W was obtained using 
polarized light microscopy. The four different samples were selected with 
the intention of their possible application for drug delivery and composition 
for them is given in Table 1. As observed in Fig.5.3.a, formulation I was 
found to be W/O type emulsion with the presence of aqueous droplets 
surrounded by reverse hexagonal (H2) phase with the characteristic fan-like 
texture. It can be seen in Fig.5.3.b that also formulation II shows fan like 
texture, characteristic of reverse hexagonal (H2) phase. Fig.5.3.c clearly 
TRI
W MO
H2 + Lα
Emulsion
Emulsion + W
L2
L2L2 + Dispersion
Oil + Dispersion + W
I
(a) (b) 
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shows maltese-crosses which is characteristic of lamellar (Lα) phase and 
hence validates lamellar LC structure of formulation III. Formulation IV did 
not show any pattern under the polarized light microscope as it was 
isotropic. This is typical of cubic phases. All the four types of samples 
prepared with CS exhibited similar microscopic pattern to the samples 
prepared according to MO/TRI/W and MO/W phase diagrams. This 
demonstrates that the caffeine added at the concentration of 10 mg/ml to 
the emulsion and LC samples did not cause significant phase transition 
among the four samples investigated here.     
 
 
Fig.5.3. Polarized light microscopy at 25 º C (a) formulation I (320X magnification) (b) 
formulation II (200X magnification) and (c) formulation III (200X magnification). 
 
5.3.2 2H NMR  
2H NMR spectra for the H2+Lα two-phase and emulsion regions of 
MO/TRI/D are reported in reference [11]. It is known that the 2H NMR 
spectra of samples prepared with D shows the quadrupolar splitting typical 
of anisotropic phases. Fig.5.4 (a) shows the results obtained for the W/O 
emulsion sample having the composition MO/TRI/D2O/CS (63/11/19/7). A 
single isotropic signal due to isotropic solution ( CS droplets of Fig.5.3.a) 
and the two clear quadrupolar splittings due to anisotropic LC phase can be 
observed, namely Δ𝜐𝜐𝑞𝑞1 = 501 Hz, Δ𝜐𝜐𝑞𝑞2 = 938 Hz, as expected from the H2 
phase which shows both 90° and 0° alignments. The results obtained for 
samples containing different amount of CS and having the composition 
MO/TO/CS (69/11/20) (formulation I) and (80/11/9) (formulation II) are 
100 µm 100 µm 100 µm
(a) (b) (c) 
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shown in Fig.5.4 (b) and (c), respectively. In the case of the sample with the 
higher amount of CS i.e. formulation I, two quadrupolar splittings, namely 
Δ𝜐𝜐𝑞𝑞1 = 576 Hz and Δ𝜐𝜐𝑞𝑞2 = 1050 Hz are observed suggesting again the 
presence H2 LC structure. Sample with relatively less amount of CS i.e. 
MO/TO/CS (80/11/9) shows four quadrupolar splittings. 
  
 
Fig.5.4. 2H NMR spectra for (a) formulation I, (b) formulation II, and (c) formulation V. 
 
The splittings Δ𝜐𝜐𝑞𝑞1 = 910 Hz and Δ𝜐𝜐𝑞𝑞2 = 1856 Hz could correspond to 
a predominant H2 phase. The less intense splittings Δ𝜐𝜐𝑞𝑞3 = 1450 Hz 
and Δ𝜐𝜐𝑞𝑞4 = 3210 Hz could be due to presence of a Lα phase. Thus, this 
sample clearly shows the biphasic nature and validates the presence of 
both LC phases, H2 and Lα, as reported previously [11]. It should be 
remarked that the splittings assigned to the H2 and to the Lα LCs do not 
fulfil the predictions of equation 2 exactly. Substantially, Δ𝜐𝜐𝑞𝑞3 should be 
almost equal to Δ𝜐𝜐𝑞𝑞2. The reason of the anomalous values may be ascribed 
3000 2000 1000 0 -1000 -2000 -3000
Hz -3000 -2000 -1000 0 1000 2000 3000
Hz
-3000 -2000 -1000 0 1000 2000 3000
Hz
 
 
 
(a) (b) 
(c) 
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to the presence of caffeine that, due to its shape, is likely to be 
preferentially located in the water layer of the lamellar phase rather than in 
the water cylinders of the reverse hexagonal phase. Caffeine partition 
should increase the effective thickness of the Lα, water layer, but subtracts 
water molecules, thus decreasing the surfactant/water (S/W) molar ratio; 
consequently the quadrupolar splitting decreases. Indeed, as depicted by 
equation 2,  Δ𝜐𝜐𝑞𝑞  of D2O in surfactant/water systems mainly depends on 
S/W, provided that enough hydration water molecules are present (nb is 
constant). Generally Δ𝜐𝜐𝑞𝑞  decreases with increasing water content.  
In conclusion, it can be suggested that the different partition of 
caffeine in the water domains of the Lα, and H2 LC phases is responsible for 
the observed anomalous quadrupolar splittings of D2O. 
 
5.3.3. SAXS  
Fig.5.5 and Table 2 show the SAXS patterns and lattice parameters 
for formulation I-IV. The SAXS study was performed to understand the 
effect of temperature on the LC structure of all formulations. The 
formulation I which was W/O type emulsion stabilized by LC phase showed 
peculiar results. We could not observe the peaks due to Lα phase, since it 
was mainly dominated by H2 phase. The lattice parameter of this sample 
decreased from about 65 to 59 Å, when it was warmed from ambient 
temperature (25 °C) to physiological temperature (37 °C). It did not revert 
back to the original lattice parameter when temperature was decreased to 
the ambient temperature; rather it decreased slightly to 58 Å. This effect 
could be due to relatively less thermal stability of the emulsion in 
comparison to LC phases, alone. Formulation II and III showed typical 
scattering pattern of H2 and Lα LC phases, respectively, from temperature 
25 to 37 °C and even when they were brought back to ambient temperature 
(25 °C). Formulation II showed a slight decrease from 60 to 59 Å with 
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increase in temperature from 25 to 37 °C and it reversed back to 59 Å after 
decreasing temperature to 25°C. Formulation III is a lamellar phase, whose 
lattice parameter fluctuates in the range of 41.9-43.6 Å. Formulation IV 
showed bicontinuous cubic phase pattern of Ia3d type. In this case lattice 
parameter decreased significantly from about 146 to 142 Å with increasing 
temperature to physiological condition. It reverts back to the original lattice 
parameter with decreasing temperature to ambient conditions.   
        
 
 
Fig.5.5. SAXS patterns with increase in temperature from 25, 32 to 37 ºC and then 
decreasing back to 25 ºC for formulation I (a), II (b), III (c) and IV (d). 
 
Table 2 Effect of temperature on lattice parameters for formulation I-IV. 
Temperature 
(ºC) → 25 32 37 25 LC structure 
I 65.0 ± 0.5 63.5 ± 0.4 59.2 ± 0.6 57.6 ± 0.7 H2 
II 59.7 ± 0.2 59.6±0.6 58.6 ± 0.5 59.2 ± 0.2 H2 
III 43.0 41.9 43.6 42.4 Lα 
IV 146.0 ± 1.0 145.0 ± 1.0 142.0 ± 0.2 144.8 ± 0.9 Ia3d 
      
25 ºC
32 ºC
37 ºC
25 ºC
25 ºC
32 ºC
37 ºC
25 ºC
25 ºC
32 ºC
37 ºC
25 ºC
25 ºC
32 ºC
37 ºC
25 ºC
(c) 
(a) (b) 
(d) 
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5.3.4. In vitro release of caffeine 
The four formulations studied here had different loading capacities 
for caffeine, because of different water content in respective formulations. It 
can be observed from Table 1 that maximum loading of caffeine was 
obtained in case of formulation IV, which had 30% water and bicontinuous 
cubic LC structure. Formulation II and III had 20% and 15% water, and H2 
and Lα LC structure, respectively. In case of formulation I, although 26% 
water was added, only 7% water was used for caffeine loading because 
19% water was required to form LC structure.    
 
Fig.5.6. In vitro release of caffeine using Franz diffusion cell. 
 
The in vitro release experiments show that about 50% of caffeine 
loaded was released in 24 hours in case of W/O emulsion (formulation I) 
samples. Lamellar LC formulation (formulation III) showed slower release 
than emulsion sample and only about 25% caffeine was released in 24 
hours. Both reverse hexagonal LC formulation (formulation II) and 
bicontinuous cubic LC formulation (formulation IV) samples showed very 
slow and similar release pattern. In both cases at the end of experiment 
only about 15% release of caffeine was found. Hexagonal phases are more 
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viscous than lamellar phases. The bicontinuous cubic phases are very stiff, 
and they behave almost like a solid [29]. Thus, the release data obtained 
here can be correlated to viscosity of the different LC phases.   The reason 
for highest release of caffeine from formulation I is that the caffeine might 
not have experienced considerable resistance from the LC phases, since it 
is mainly present in the water droplets of the emulsion.    
Similarity between the release curves can further be elucidated by 
the similarity factor, F2, described by FDA, which can be calculated using 
the following equation: 
 
𝐹𝐹2 = 50 × 𝑙𝑙𝑓𝑓𝑎𝑎 ��1 + 1𝑛𝑛�(𝑅𝑅𝑟𝑟 − 𝑇𝑇𝑟𝑟)2𝑛𝑛
𝑟𝑟=1 �
−0.5 × 100� (3) 
where n is the number of time points, Rt is the amount released of a 
reference product and Tt is the amount released for the test product at time 
t. If F2 is between 50 and 100, the two profiles are considered to be similar 
and bioequivalent [30]. 
When the release data for formulation I are compared with that of 
formulation II, III and IV, F2 values were 36.5, 44.6 and 37 respectively. 
This proves that the formulation I, which is a W/O emulsion shows a 
completely different release pattern. Comparing the release data for 
formulation II with that of formulation III and IV, the calculated F2 values are 
61.3 and 96, respectively. This proves that formulation II, which has mainly 
reverse hexagonal structure, releases caffeine at a similar rate to that of 
formulation IV having bicontinuous cubic structure. The final amount 
released in case of formulation III (lamellar phase) (about25%) was found 
to be significantly higher than that from formulation II (reverse hexagonal 
phase) (about 15%), nevertheless the initial release for the first eight hours 
was very similar. Hence the F2 comparison suggests that these two 
formulations are not significantly different in releasing caffeine. The F2 
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value was found to be 63.4, when comparison between release data for 
formulation III (lamellar phase) and formulation IV (bicontinuous cubic 
phase) was done. This shows that formulation III and IV are also similar in 
releasing caffeine. Thus, only significant difference in release of caffeine is 
found in case of emulsion sample. 
 
5.4. Conclusions 
The monoolein based formulations for caffeine were characterized by 
polarized light microscopy, 2H NMR and SAXS. The LC structure did not 
change, at a macroscopic level, as result of caffeine addition. SAXS study 
proved that temperature changes from ambient to physiological conditions 
and then reverting back to original temperature can cause significant 
variations in lattice parameter of LC phases that stabilize W/O emulsion 
system. The in vitro release of caffeine from these formulations was in the 
range of 15-50% of the loaded amount of the caffeine after 24 hours. This 
preformulation data can be used to design an appropriate 
topical/transdermal drug delivery system. Further studies are in progress to 
understand the diffusion across the biological membrane, and to obtain 
optimized procedures for the preparation of the formulations. 
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CONCLUDING REMARKS 
 
In last few decades, smart nanostructured materials, for instance, 
triblock copolymers with thermoreversible properties, silica nanoparticles 
with different organic functionalizations, and lipids possessing ability to form 
different lyotropic liquid crystalline structures, have drawn attention to 
obtain novel drug delivery systems. These drug delivery systems are highly 
advantageous over conventional pharmaceutical dosage forms, since they 
can be tailor-made to achieve controlled release of therapeutic drug 
molecules.  
In this PhD thesis, the use of different non-ionic surfactants to 
prepare and characterize smart nanostructured drug delivery systems was 
investigated. The focus was on the evaluation of effectiveness of these 
systems to modulate the in vitro release properties of a model protein such 
as lysozyme and, a small drug molecule such as caffeine. 
Chapter 3 discusses the system consisting of gelatin microspheres 
suspended in thermoreversible Pluronic F127 (PF 127) gel. The 
characterization of the gelatin microspheres (GMs) crosslinked by two 
different cross-linkers viz. D-glucose and glutaraldehyde was done by 
Scanning Electron Microscopy (SEM) and ATR-FTIR technique. Evidence 
of the spherical shape and different degree of cross-linking was provided. 
Aqueous PF 127 gel (20 % w/v) with the presence and the absence of 
GMs, were, characterized for rheology and for gel microstructure by Small 
Angle X-ray Scattering (SAXS). Sol-gel transition temperature of PF 127 gel 
was mostly unaffected when either glucose or glutaraldehyde crosslinked 
microspheres were suspended in them. It was found about 22 ⁰C indicating 
feasibility of formulations for therapeutic applications. SAXS study 
confirmed that the PF 127 gel microstructure was a discrete cubic liquid 
crystal of Fm3m type and it was not significantly affected by the presence of 
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0.5 % w/v of both the types of microspheres. The release of lysozyme from 
both types of crosslinked GMs was successfully controlled when they were 
suspended in PF127 gel. 
Chapter 4 discusses about the application of ordered mesoporous 
materials (OMMs) as matrices for drug delivery systems. A comparison was 
made between the widely studied SBA-15 mesoporous silica with that of 
less investigated MSE mesoporous organosilica, towards the adsorption (at 
pH 7.0 and 9.6) and in vitro controlled release of lysozyme. Both OMMs 
have a hexagonal ordered mesoporous structure and texture, as confirmed 
by SAXS, TEM and N2 adsorption isotherms, but differ for the chemical 
composition and surface charge density, as determined by ATR-FTIR 
spectroscopy and potentiometric titrations, respectively. Rather than the 
structural and textural features, the different chemical composition of SBA-
15 and MSE seems to be responsible of the different lysozyme loading and 
release, and of the different stability towards the lixiviating action of the 
physiological medium. 
Chapter 5 discusses the use of monoolein to form W/O emulsion and 
liquid crystalline formulations, including reverse hexagonal, lamellar, and 
bicontinuous cubic formulations. Caffeine, chosen as a model drug, was 
added to these formulations at the concentration of 10mg/ml. The 
formulations were then characterized by polarized light microscopy, NMR 
and SAXS. It was found that they did not change the liquid crystalline 
structure significantly due to the presence of caffeine. The loading capacity 
for caffeine solution in these formulations varied between 7 and 30% of the 
weight of the formulations. The in vitro release of caffeine from these 
formulations was in the range of 15-50% of the loaded amount of the 
caffeine after 24 hours. The preformulation data obtained here can be 
useful to design an appropriate topical/transdermal drug delivery system. 
